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Dicebat Bernardus Carnotensis
nos esse quasi nanos,
gigantium humeris insidentes,
ut possimus plura eis et remotiora videre,
non utique proprii visus acumine,
aut eminentia corporis,
sed quia in altum subvenimur et
extollimur magnitudine gigantea.
(John of Salisbury)
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Resumo
Demência por doença de Alzheimer (DA) é uma síndrome clínica caracterizada por múlti-
plos problemas cognitivos, incluindo dificuldades na memória, funções executivas, lingua-
gem e habilidades visuoespaciais. Sendo a forma mais comum de demência, essa doença
mata mais do que câncer de mama e de próstata combinados, além de ser a sexta prin-
cipal causa de morte nos Estados Unidos. A neuroimagem é uma das áreas de pesquisa
mais promissoras para a detecção de biomarcadores estruturais da DA, onde uma técnica
não invasiva é usada para capturar uma imagem digital do cérebro, a partir da qual es-
pecialistas extraem padrões e características da doença. Nesse contexto, os sistemas de
diagnóstico assistido por computador (DAC) são abordagens que visam ajudar médicos e
especialistas na interpretação de dados médicos, para fornecer diagnósticos aos pacientes.
Em particular, redes neurais convolucionais (RNCs) são um tipo especial de rede neural
artificial (RNA), que foram inspiradas em como o sistema visual funciona e, nesse sentido,
têm sido cada vez mais utilizadas em tarefas de visão computacional, alcançando resulta-
dos impressionantes. Em nossa pesquisa, um dos principais objetivos foi utilizar o que há
de mais avançado sobre aprendizagem profunda (por exemplo, RNC) para resolver o difí-
cil problema de identificar biomarcadores estruturais da DA em imagem por ressonância
magnética (IRM), considerando três grupos diferentes, ou seja, cognitivamente normal
(CN), comprometimento cognitivo leve (CCL) e DA. Adaptamos redes convolucionais
com dados fornecidos principalmente pela ADNI e avaliamos no desafio CADDementia,
resultando em um cenário mais próximo das condições no mundo real, em que um sis-
tema DAC é usado em um conjunto de dados diferente daquele usado no treinamento. Os
principais desafios e contribuições da nossa pesquisa incluem a criação de um sistema de
aprendizagem profunda que seja totalmente automático e comparativamente rápido, ao
mesmo tempo em que apresenta resultados competitivos, sem usar qualquer conhecimento
específico de domínio. Nomeamos nossa melhor arquitetura ADNet (Alzheimer’s Disease
Network) e nosso melhor método ADNet-DA (ADNet com adaptação de domínio), o qual
superou a maioria das submissões no CADDementia, todas utilizando conhecimento pré-
vio da doença, como regiões de interesse específicas do cérebro. A principal razão para
não usar qualquer informação da doença em nosso sistema é fazer com que ele aprenda
e extraia padrões relevantes de regiões importantes do cérebro automaticamente, que po-
dem ser usados para apoiar os padrões atuais de diagnóstico e podem inclusive auxiliar em
novas descobertas para diferentes ou novas doenças. Após explorar uma série de técnicas
de visualização para interpretação de modelos, associada à inteligência artificial explicável
(XAI), acreditamos que nosso método possa realmente ser empregado na prática médica.
Ao diagnosticar pacientes, é possível que especialistas usem a ADNet para gerar uma di-
versidade de visualizações explicativas para uma determinada imagem, conforme ilustrado
em nossa pesquisa, enquanto a ADNet-DA pode ajudar com o diagnóstico. Desta forma,
os especialistas podem chegar a uma decisão mais informada e em menos tempo.
Abstract
Dementia by Alzheimer’s disease (AD) is a clinical syndrome characterized by multiple
cognitive problems, including difficulties in memory, executive functions, language and
visuospatial skills. Being the most common form of dementia, this disease kills more than
breast cancer and prostate cancer combined, and it is the sixth leading cause of death
in the United States. Neuroimaging is one of the most promising areas of research for
early detection of AD structural biomarkers, where a non-invasive technique is used to
capture a digital image of the brain, from which specialists extract patterns and features
of the disease. In this context, computer-aided diagnosis (CAD) systems are approaches
that aim at assisting doctors and specialists in interpretation of medical data to provide
diagnoses for patients. In particular, convolutional neural networks (CNNs) are a special
kind of artificial neural network (ANN), which were inspired by how the visual system
works, and, in this sense, have been increasingly used in computer vision tasks, achieving
impressive results. In our research, one of the main goals was bringing to bear what is
most advanced in deep learning research (e.g., CNN) to solve the difficult problem of iden-
tifying AD structural biomarkers in magnetic resonance imaging (MRI), considering three
different groups, namely, cognitively normal (CN), mild cognitive impairment (MCI), and
AD. We tailored convolutional networks with data primarily provided by ADNI, and eval-
uated them on the CADDementia challenge, thus resulting in a scenario very close to the
real-world conditions, in which a CAD system is used on a dataset differently from the one
used for training. The main challenges and contributions of our research include devising
a deep learning system that is both completely automatic and comparatively fast, while
also presenting competitive results, without using any domain specific knowledge. We
named our best architecture ADNet (Alzheimer’s Disease Network), and our best method
ADNet-DA (ADNet with domain adaption), which outperformed most of the CADDe-
mentia submissions, all of them using prior knowledge from the disease, such as specific
regions of interest of the brain. The main reason for not using any information from the
disease in our system is to make it automatically learn and extract relevant patterns from
important regions of the brain, which can be used to support current diagnosis standards,
and may even assist in new discoveries for different or new diseases. After exploring a
number of visualization techniques for model interpretability, associated with explain-
able artificial intelligence (XAI), we believe that our method can be actually employed in
medical practice. While diagnosing patients, it is possible for specialists to use ADNet to
generate a diversity of explanatory visualizations for a given image, as illustrated in our
research, while ADNet-DA can assist with the diagnosis. This way, specialists can come
up with a more informed decision and in less time.
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Chapter 1
Introduction
Dementia by Alzheimer’s disease (AD) is a clinical syndrome characterized by multiple
cognitive problems, including difficulties in memory, executive functions, language and
visuospatial skills. Inexorably eroding the lifetime of memories and cognitive capacities
that define us as individuals, AD robs patients of their unique identity, leading them to
complete dependency for basic functions of daily life and ultimately to death.
Being the most common form of dementia, this disease kills more than breast cancer
and prostate cancer combined, and it is the sixth leading cause of death in the United
States [4]. Over a decade ago, nearly 25 million people lived with dementia worldwide,
and 4.6 million new cases arise every year [23]. In Brazil specifically, there is a lack of
general information regarding incidence and prevalence of AD dementia, but previous
studies suggested that around 7% of the aged population is affected, and the incidence
is estimated at 55 000 new cases each year [33]. By far, the single greatest risk for AD
is aging, as there is almost a 15-fold increase in the prevalence of dementia between the
ages of 60 and 85 years [21]. Markedly, the projected burden of the disease represents a
looming healthcare crisis as the population of most industrialized countries continues to
grow older.
The classic neuropathology of AD prominently includes intracellular aggregates of hy-
perphosphorylated tau protein that disrupt microtubule organization, and diffuse extracel-
lular amyloid β-protein (Aβ) deposition [65]. These pathological events are accompanied
by reactive microgliosis, oxidative stress and brain inflammation [31]. The loss of neurons
and synapses result in a slow and progressive degeneration of brain structures, which
can be seen as a dramatic cerebral shrinkage in structural magnetic resonance imaging
(sMRI). Atrophy is especially severe in the hippocampus and temporal structures, which
are areas that play a key role in the formation of new memories, and other cortical regions
are also affected, such as parietal and frontal cortices.
Although there is still not a cure, it is possible to treat both cognitive and behavioral
symptoms of AD. The early diagnosis of the disease is paramount, not to say the most
important hope, since it benefits patients’ treatment and gives them more time to plan for
the future. Moreover, clinical trials in AD tend to enroll subjects at earlier time-points,
before neuronal degeneration has achieved a certain stage and treatment might be more
effective. Even though detecting AD at early stages is difficult, a few biological markers
(biomarkers) have been studied and defined. In short, a biomarker is an objectively
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measurable characteristic, which supports the accuracy of diagnosis, being particularly
important for AD, given that about 10% to 15% of AD cases are misdiagnosed [76].
Furthermore, biomarkers also serve as indirect measures of disease severity, and changes in
biomarkers following intervention can be important indicators of alterations in the severity
or stage of a disease. One of the main biomarkers for AD is the level of Aβ and tau proteins
from the cerebrospinal fluid [53], which can be obtained through a considerably invasive
procedure. As such, it is important to consider and evaluate different potential AD
biomarkers, especially less invasive ones, for instance, using magnetic resonance imaging
(MRI) or positron-emission tomography (PET).
Neuroimaging is one of the most promising areas of research for early detection of AD,
where a non-invasive technique is used to capture a digital image of the brain, from which
specialists extract patterns and features of the disease. In 2011, anatomical MRI was
included as evidence for neurodegeneration even in the prodromal stage of AD [70], i.e.,
mild cognitive impairment (MCI), helping with the diagnosis by identifying specific pat-
terns of atrophy that are characteristic of the disease. Amnestic MCI (aMCI), specifically,
is a well-recognized risk factor for AD development, which is characterized by a cognitive
decline in memory and possibly other domains, but without significant impairment in
social and functional performance, i.e., absence of dementia [2].
Computer-aided diagnosis (CAD) systems are approaches that aim at assisting doctors
and specialists in interpretation of medical data to provide diagnoses for patients. This is
an interdisciplinary field, joining forces from medicine and computer science, that gained
traction in 1980s, mostly due to performance improvements at the time and acceptance
by radiologists [17].
Some samples from the training set of the computer-aided diagnosis of dementia (CAD-
Dementia) challenge [9], based on structural MRI data, are illustrated in Figure 1.1, where,
(a) Cognitively normal (train_vumc_007 ).
(b) Alzheimer’s disease (train_emc_009 ).
Figure 1.1: Anatomical planes of cognitively normal and Alzheimer’s disease individuals
from CADDementia training set. In (b), we can observe an atrophy mainly in temporal
structures, such as the hippocampus, and posterior parts of the parietal cortex.
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in (b), we can observe an atrophy mainly in temporal structures, such as the hippocampus,
and posterior parts of the parietal cortex. In particular, the Alzheimer’s Disease Neu-
roimaging Initiative (ADNI) [54] certainly is spearheading most of current efforts for data
collection and research goals, and many researchers have used data provided by ADNI in
order to evaluate CAD systems for AD, including techniques from machine learning and
computer vision areas.
In short, machine learning is an area of computer science, which explores algorithms
that can learn patterns from data, and then make further predictions. Considering a
CAD system based on image data, there will typically be a medical specialist explaining
the patterns and characteristics within the images to a computer vision specialist, which
will then translate this knowledge into image processing techniques and machine learning
models.
In general, these systems learn from data by adapting a set of internal parameters,
which are internal configuration variables that define and control the behavior of the al-
gorithm. Usually, models that have a larger number of parameters are capable of learning
more complex patterns and arrangements from the provided data. On the other hand,
having too many parameters will also imply in longer times for training (optimization)
and execution, as well as in an increased chance of overfitting, where a model memorizes
training data, instead of actually learning meaningful patterns. The ability to accurately
predict previously unseen data is referred to as generalization.
Deep learning, an alias for artificial neural networks (ANNs), is a machine-learning
technique inspired by how the brain works. Historically, traditional machine-learning
approaches involved specialists for manually designing hand-crafted features for each task,
which were then fed to a classifier or regressor. On the other hand, ANNs are capable
of taking raw data as input, and automatically learn discriminative representations in a
hierarchical way. This is an interesting approach to both corroborate previous findings
by specialists, and to eventually assist in new discoveries. In particular, convolutional
neural networks (CNNs) are a special kind of ANNs, which were inspired by how the
visual system works, and, in this sense, have been increasingly used in computer vision
tasks, achieving important results.
The primary unit in ANNs is a neuron, which basically receives a value as input, pro-
cesses it by applying a mathematical function, and then outputs the result. A traditional
ANN architecture is composed of a number of layers, where a layer is simply a stack of one
or more neurons. These layers are organized hierarchically, where a given layer receives
input from the previous layer, processes this information, and then passes these values to
the next layer. In general, an ANN has one input layer, which is the provided data, one
output layer, which is the prediction made by the network, and an arbitrary number of
hidden layers between them, where more layers represent higher complexity. For further
information on deep learning, we refer the reader to Goodfellow et al. [29].
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1.1 Related Work
In terms of AD, prior research analyzed a number of classification tasks, including dis-
tinguishing between cognitively normal (CN), MCI, and AD. Additionally, considering
conversions from diagnosed MCI to AD range only from 10.2% to 33.6% in a year [83],
there is also the challenging task of differentiating between MCI patients who will con-
vert to AD (MCI converters, MCIc) and MCI patients who will not convert to AD (MCI
non-converters, MCInc). Even though we do not intend to review CAD systems for AD,
we present here prior research somewhat extensively, in order to emphasize our challenges
and contributions.
Works in this area have recurrently considered only a small number of subjects and
images, often with curated data (i.e., reviewed, prepared and organized by experts), such
as ADNI’s Standardized MRI Data Sets [88]. Additionally, with the lack of a standard
evaluation protocol, each study employed its own criteria, with its own random data
split. This not only hinders comparison between different methods, but it also usually
overestimates their performance in a real-world scenario, where data will not be readily
preprocessed, and will most likely come from different sources. In this sense, a few works
reviewed multiple techniques for the Alzheimer’s biomarker identification task, and, more
recently, a few challenges with standard protocols and hidden test labels were launched,
such as the CADDementia challenge [9]. As a side note, the ineffectiveness in compar-
ing results was our main motivation to focus in describing techniques, rather than their
performance metrics in this work.
Training deep learning systems usually requires large amounts of data, and most
datasets are in the range of a few hundred samples. In order to overcome this limitation,
studies that make use of deep-learning methods usually extract multiple small regions of
the brain, thus generating thousands of input data. Differently from this approach, our
method considers the whole brain when optimizing the networks, in an exploratory fash-
ion, making it particularly interesting for automatically determining the most effective
regions. This was also a reason for our emphasis on dataset sizes and their respective
image dimensions in the description of related works.
1.1.1 Alzheimer’s Disease
Many CAD systems for AD using sMRI have been proposed in prior art, and they usually
achieve promising results. However, most of these works evaluate systems on their own
non-disclosed data, or use their own split of available data, which makes comparisons
between different methods very difficult.
Falahati et al. [22] reviewed several AD classification and MCI conversion prediction
studies, focusing on sMRI. The main idea was to train a system for classification between
CN and AD, and then evaluate them on CN vs. AD, and MCIc vs. MCInc. The authors
indicated that performances for methods using small sample sizes are usually superior
than the ones using larger datasets or external validation sets, which is probably due
to overfitting or very small homogeneous samples. Besides data, different approaches
for feature extraction, feature selection, classification, and, more importantly, validation
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hamper comparisons across different works.
Cuingnet et al. [14] evaluated ten methods, namely, five based on voxel, three based
on cortical thickness, and two based on hippocampus. Using 509 subjects from the ADNI
database, they compared these methods on three different scenarios, which were classi-
fication between CN and AD, CN and MCIc, and MCIc and MCInc. They found that
methods based on voxel or cortical thickness achieved high accuracies on CN vs. AD.
However, CN vs. MCIc had considerably inferior results, while MCIc vs. MCInc did not
perform statistically different from chance. Additionally, the authors noted that most clas-
sification errors were oldest controls and youngest patients, which was partially explained
by the brain atrophy associated with normal aging.
Similarly, Sabuncu and Konukoglu [62] collected 810 samples from ADNI and 415 from
OASIS (cross-sectional study [49]), and analyzed a combination of four feature sets with
three algorithms, to distinguish CN vs. AD, and CN vs. MCI. Features included volumes
of anatomical structures, average thickness within specific cortical parcellations, and cor-
tical thickness, while algorithms included support vector machine (SVM), neighborhood
approximation forest, and relevance voxel machine. Results indicated that accuracy and
relevance of image-derived measurements are more important than the prediction algo-
rithm for the overall performance, but data quality and sample size play even bigger roles.
Moreover, even though cross-validation is an interesting technique to measure accuracy,
it is generally optimistic in terms of generalization, especially when the trained system
is applied to an independent dataset, due to data acquisition protocol, composition of
populations, and application of diagnostic criteria or clinical tests.
Advancing research for comparison of different methods, the Alzheimer’s Disease Big
Data DREAM Challenge #1 [3], in subchallenge 3, proposed a standard evaluation proto-
col, including defined data for training (628 entries from ADNI), and testing (182 entries
from AddNeuroMed [46]). Available data contained sMRI, and other variables, such
as years of education, and genotypes. The objective was to predict Mini-Mental State
Examination (MMSE) scores and diagnostic classes, and the winning method achieved
a correct diagnosis percentage of 60.2%, considering CN, MCI, and AD classes. This
method combined both clinical and image features, with volume of hippocampus being
the most important one.
Equivalently, Bron et al. [9] launched the CADDementia challenge, a standard com-
parison between different methods for classification within CN, MCI, and AD classes, with
the same defined data and evaluation protocol. Teams had only 30 sMRI scans available
for training, and 354 scans with hidden diagnoses (including group priors) for testing. The
main idea was to leverage existing public data to optimize the classification system, which
could then be optimized again or just fine-tuned on a different small dataset, leaving a
larger number of unseen images to evaluate performance. This is a very interesting pro-
tocol, as it more closely relates to a real-world scenario, where an algorithm would need
to be adapted for a practical clinical setting. In this challenge, most approaches used
volume, thickness, intensity, and shape features from specific regions of interest, along
with regression, support vector machine, and random forest for classification.
The winning method [69] achieved an accuracy of 63.0%, using a number of individual
MRI imaging biomarkers, with hippocampal volume, ventricular volume, hippocampal
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texture, and parietal lobe thickness being the most important characteristics. Data from
both ADNI and AIBL [19] were used for training the system, which used a linear dis-
criminant analysis classifier. It is important to note that hippocampal shape scores used
transductive inference, thus needing the CADDementia test data to be calculated. Even
though this is a valid approach, it deviates from the original proposal of a practical clinical
setting. Additionally, their pipeline failed to process three scans from the CADDementia
test set, requiring manual intervention. The analysis of each subject took 19 hours of
computation time.
The second best team [82] employed a domain-adaptation approach. Their idea was
to weight samples from a source dataset according to a target dataset distribution, and
five different weighting techniques were evaluated on 751 subjects from ADNI, and 215
from AIBL. However, the system submitted to the challenge corresponds to the fourth
best accuracy in their experiments, indicating that there is still room for improvement.
More specifically for the challenge, optimization was done on the union of ADNI and
CADDementia training sets, with equal weights for each sample. Classification was done
by a generalized linear model, using volume, cortical thickness, and shape features. The
analysis of each subject took 17.4 hours of computation time.
1.1.2 Deep Learning
One of the first successful real-world applications of convolutional neural networks (CNNs)
was a system to read checks [41, 42]. More recently, a variety of computer vision ap-
proaches have been evaluated at the ImageNet Large-Scale Visual Recognition Challenge
(ILSVRC) [61], which is held yearly and involves different tasks, such as general object
recognition and localization. Since the first entry using deep CNNs [40], this technique
has dominated the top results in this contest. Thus, it is very interesting to have a better
understanding on how it would behave in the AD task.
Suk and Shen [72] presented one of the first works using ANN for the Alzheimer’s
biomarker identification task, extracting some low-level features, which were then fed to
a stacked auto-encoder (SAE) with three hidden layers. To optimize the parameters, a
greedy layer-wise unsupervised learning approach was used. Then, learned layers were
stacked together with a new output layer, and the whole network was fine-tuned with
labeled data. Next, original low-level features were concatenated with SAE latent feature
representation, i.e., outputs from the last hidden layer, generating an augmented feature
vector. Finally, a multi-task and multi-kernel support vector machine was trained to
predict class labels, MMSE, and AD assessment scale-cognitive subscale (ADAS-Cog)
scores.
Li et al. [44] presented one of the first methods using 3D CNNs for the Alzheimer’s
biomarker identification task, although indirectly. The main idea was to adopt both MRI
and PET scans to perform the diagnosis; however, a number of subjects only had the MRI
modality. Given an MRI, the proposed method used a CNN to predict the corresponding
PET scan. Images were first resized to 64 × 64 × 64, and 50 000 random patches of size
15× 15× 15 were extracted from each image. Finally, with this input patch, a CNN with
two hidden convolutional layers and 37 761 parameters outputs a 3× 3× 3 PET patch.
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Suk et al. [73] introduced an approach using deep Boltzmann machine (DBM), which
comprises restricted Boltzmann machine (RBM) as building blocks. Similarly to previous
methods, both MRI and PET scans were used, being resized to 64×64×64 voxels, with a
final voxel size of 4×4×4mm3. Discriminative patches of size 11×11×11 were extracted,
and then fed to a Gaussian DBM. This architecture comprised two networks of two hidden
layers each for independent MRI and PET patches processing, which were concatenated
and then followed by three hidden layers for a multimodal DBM (MM-DBM). Features
extracted by this DBM were used in an image-level hierarchical SVM classifier.
Payan and Montana [56] randomly extracted 5×5×5 patches from 68×95×79 images,
which were flattened into an 125 dimensional input array, and fed to an overcomplete
sparse autoencoder with 150 units. Each unit was rearranged into a 5 × 5 × 5 filter,
which was convolutionally applied to the complete original image. Next, outputs went
through max-pooling, and a fully-connected layer, followed by the output layer. Therefore,
even though the proposed is conceptually similar to a 3D CNN, in practice, it was a
reinterpretation of the autoencoder units, followed by a traditional neural network.
Hosseini-Asl et al. [34] employed a stack of unsupervised 3D convolutional autoencoder
(3D-CAE), and used the whole brain. All 30 images from the CADDementia training set
were used as source domain, being preprocessed and normalized to 200 × 150 × 150.
These images were used to greedily train three stacked 3D-CAEs in a layer-wise fashion.
The output of the last layer was flattened and used as features in a traditional fully-
connected layer with two hidden layers, which was trained on a target domain. Even
though this method could be directly applied to the CADDementia challenge, it was only
cross-validated on ADNI.
Sarraf et al. [64] decomposed 4D resting-state functional MRI (rs-fMRI) and 3D struc-
tural MRI into 2D images, with 2× 2× 2 mm3 resolution in standard space. Then, two
2D CNN architectures were evaluated for the CN vs. AD task, namely, LeNet-5 [42] and
GoogLeNet [74]. Despite being a reasonable approach, it is unclear which axis shall pro-
vide best results, and, even if the decomposition is performed along all axes, this method
will still not be able to find discriminative 3D patterns within the data.
Korolev et al. [39] is one of the works that most closely relates to ours. They designed
3D CNNs based on smaller versions of VGG [68] and ResNet [32] architectures, which
were trained on whole-brain images of size 110 × 110 × 110. The 231 images used were
a subset of previously processed MRIs from ADNI, and included CN, early MCI (eMCI),
late MCI (lMCI), and AD subjects. However, they only considered binary classification
tasks, which were evaluated using cross-validation on ADNI, hindering better comparisons
with our method. On the other hand, we proposed a multiclass approach that included
very deep CNN architectures, with large input images, and which was evaluated on the
CADDementia challenge, making our results more reliable.
Dolph et al. [18] were the first group to successfully propose a deep-learning approach
to the CADDementia challenge, with a technique similar to Suk and Shen [72]. Basi-
cally, they extracted sub-cortical features, such as cortical thickness, surface area, and
volumetric measurements, along with texture features from gray-level co-occurrence ma-
trix in fractal dimension. These values were used to greedily layer-wise train a stacked
auto-encoder with three hidden layers, achieving competitive results in the challenge.
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Finally, Brosch and Tam [10] proposed and evaluated a fast training method for CNNs
using fast Fourier transforms (FFTs). The authors stated that this approach made it
practical to train a 3D CNN with two hidden layers, considering input images as large
as 128 × 128 × 128 voxels. This work illustrates the difficulty in training very deep 3D
CNNs, especially with high-resolution images.
The main drawbacks of the aforementioned deep-learning approaches are the small
depth of proposed networks, and the small dimensions of input images. While a network
with only a few hidden layers is not able to identify complex patterns within the data,
having a small resolution image only makes this task even more difficult. These character-
istics are present across different methods largely due to hardware constraints. In order to
reduce computational costs, we custom-tailor specific network architectures herein, and
adapt traditional optimization approaches, making such training practical.
1.2 Contributions
In our research, one of the main goals was bringing to bear what is most advanced in
deep learning research (e.g., CNN) to solve the difficult problem of identifying AD in
MRI, considering three different groups, namely, CN, MCI, and AD. From LeNet-5 [42]
to Residual Nets [32], we explored a number of state-of-the-art CNN architectures, which
are better described in Chapter 2, along with details of our methodology. We tailored
convolutional networks with data primarily provided by ADNI [54], and evaluated them
on the CADDementia challenge [9], thus resulting in a scenario very close to real-world
conditions, in which a CAD system is used on a dataset differently from the one used for
training. Our experimental setup is explained in Chapter 3.
The main challenges and contributions of our research include devising a deep-learning
solution that is both completely automatic and comparatively fast, while also presenting
competitive results, without using any domain-specific knowledge. In the end, our system
does not need any manual intervention, and runs 80× faster than the state of the art,
on average. Our best model outperformed most of the CADDementia submissions, all
of them using prior knowledge from the disease, such as specific regions of interest. The
main reason for not using any information from the disease in our system is to empower it
to automatically learn and extract relevant patterns from important regions of the brain,
which can be used to support current diagnosis standards, and may even assist in new
discoveries for different or new diseases.
Additionally, our generated ADNet and ADNet-DA models will be publicly available
along with this work, including all supporting code to both use them or to train similar
models on new data, which, to the best of our knowledge, has not been done before in
this area. In Chapter 4, we provide more details of our results and the corresponding
discussion, including a number of techniques related to explainable artificial intelligence
(XAI), in order to to visualize and have a better understanding of what the CNN has
learned and how it processes inputs, aiming at biological significance. Finally, we conclude
and present possible further explorations in Chapter 5, with due acknowledgements at the
end.
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Chapter 2
Methodology
To the best of our knowledge, we are the first group to propose an end-to-end deep 3D
CNN for the multiclass AD biomarker identification task. In terms of deep learning, a
number of existing methods rely on a greedy layer-wise learning of stacked (regular or
convolutional) autoencoders, and we believe this is mainly due to the high complexity in
optimizing a very deep 3D CNN with limited data and hardware, even considering current
standards.
In this chapter, we provide details of our pipeline, including image preprocessing, CNN
architectures, and optimization techniques. In particular, it is important to highlight the
reason we did not use images in their original space, and the need for a fixed brain
size. Even though convolutional layers can operate on data with variable dimensions,
optimizing a deep-learning system using images without any standard requires it to learn
discriminative patterns invariant to a number of transformations, such as translation,
scaling, and rotation. This would demand larger models, with increasing training times,
and an even larger number of samples, with all expected variations. By registering our
images to a standard template, we can expect similar structures to be roughly in the
same spatial location, hence we can handle the entire image at once, and automatically
determine the most important regions of interest.
2.1 Brain Extraction and Normalization
We used the Advanced Normalization Tools (ANTs) [5] version 2.1.0 to extract and nor-
malize brain images. Since this is not the focus of our research, our pipeline was based on
previously defined scripts1 [6, 80], and we made use of the provided default parameters,
including transformation types, sequence, and metrics. We refer the reader to the code
repository for more details on these parameters. Essentially, our brain extraction and
normalization pipeline comprises the following steps:
1. Winsorize image intensities on 1% and 99.9% quantiles
2. Bias field correction using N4 [79], a variant of the popular nonparametric nonuni-
form intensity normalization (N3) algorithm
1Specifically, scripts antsBrainExtraction.sh and antsRegistrationSyNQuick.sh
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3. Winsorize image intensities on 0.5% and 99.5% quantiles
4. Translation alignment using center of mass
5. Rigid transform (rotation and translation)
6. Affine transform (shearing and scaling)
7. Deformable symmetric normalization (SyN) transform (non-linear)
8. Application of brain mask from atlas
9. Normalization of intensities to [0, 1]
Winsorizing is a statistical transformation that minimizes effect of outliers. This is
achieved by replacing extreme values with the corresponding defined percentiles [16]. As
we used registered brains in our research, we opted for a less rigid and less linear atlas,
allowing some degree of variation during the registration process, and which also had a
high-spatial resolution, so finer details would not be lost in the process. As such, the
Montreal Neurological Institute (MNI) 152 International Consortium for Brain Mapping
(ICBM) 2009c Nonlinear Asymmetric 1× 1× 1 mm3 [12, 24, 25] atlas was chosen, and is
illustrated in Figure 2.1. This is an unbiased standard MRI template brain volume from
a normal population, meaning that even better registration results could be achieved by
using an atlas specific for Alzheimer’s population, i.e., including subjects diagnosed with
Alzheimer’s, and elder controls. We display some intermediate results from our pipeline
in Figure 2.2.
After the brain extraction and normalization process, the output image has the same
dimensions as the atlas, i.e., 193×229×193. From all these 8 530 021 voxels, only 1 886 574
(22%) of them are not zero. Since the brain is enclosed in a smaller region inside the
(a) Original template.
(b) Template after brain mask application.
Figure 2.1: Anatomical planes of the atlas used for registration (MNI 152 ICBM 2009c
Nonlinear Asymmetric).
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(a) Original image (train_vumc_007 ).
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(b) Image after registration.
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(c) Image after brain mask application.
Figure 2.2: Anatomical planes of a cognitively normal individual: (a) original image, (b)
after registration, and (c) after brain mask application. Coordinates are in MNI space.
image, we removed the border dimensions that contained no information, resulting in a
final image of 145 × 182 × 155. This new space represents 48% of the original volume,
reducing sparsity from 78% to 54%. Finally, we normalized the data to zero mean and
unit variance, using the training set to compute these parameters, and then applying
them to other sets. Given that the used datasets did not fit in main memory, we adopted
a single-pass online mean and estimated variance algorithm [87].
2.2 Convolutional Neural Network
CNNs have been used for many different computer vision tasks, and often achieving state-
of-the-art results. In face of this, we decided to explore this technique for Alzheimer’s
biomarker identification. To this end, we considered the ImageNet Large-Scale Visual
Recognition Challenge (ILSVRC) [61] as reference. This contest is held yearly, for some
computer vision tasks, such as general object recognition. Analyzing the techniques that
achieved the best results in the last few years, we selected some of these distinct models,
adapting them to our task. We additionally selected a smaller and older architecture to
contrast with current larger and deeper models.
We describe here the general architecture and adopted modifications. We refer the
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reader to the specific papers for a more detailed description. The most natural adaptation
was to convert all 2D operations, such as convolution or pooling, to 3D ones, since these
networks were originally designed for 2D color images, while we are dealing with 3D
grayscale MRIs.
Given such adaptations, we were unable to directly employ a transfer learning ap-
proach [66] with the original networks. In short, the idea is to pre-train a network on a
different problem with a different set of images, and then take advantage of this network
on a new task, either as a feature extractor, or as a good starting point for another op-
timization, also known as fine-tuning, instead of using random weights. In principle, we
could make an odd adaptation of the first convolutional layer from a traditional 2D CNN
trained on color images, since it has a 3D shape; however, these filters will most likely
be optimized to find 2D color patterns, instead of 3D patterns. Additionally, we could
not find any publicly available trained model for the AD task. As such, with this work,
we are releasing one of the first models ready to be used, encouraging open science and
reproducible research, while also setting a starting point for researchers working with 3D
MRIs.
Architecture Layers Parameters(in millions)
LeNet-5 7 0.3
VGG 2048 11 89.8
VGG 512 11 26.8
GoogLeNet 22 14.6
ResNet A 18 33.0
ResNet B 18 33.2
Table 2.1: Description of evaluated CNN architectures.
A common attribute to all considered architectures is that spatial dimension is reduced
as information flows to deeper layers. This is usually achieved with max-pooling layers,
or with larger strides in convolutional layers. In order to accommodate our different
data shapes that were not necessarily divisible by two, we adopted an ad-hoc approach
by zero-padding each layer as needed, so no information was lost. We also added batch
normalization [35] to every convolutional and fully-connected layers. All activation func-
tions were rectified linear units (ReLU) [55], defined as f(x) = max(0, x), except for the
classification output, which was a softmax function. Finally, the exact number of layers
or depth varied according to the adopted network standard. In Table 2.1, we took into
account the original approach for each network, highlighting eventual differences along
with their descriptions.
We started with a small network, based on the LeNet-5 [41, 42] architecture. Con-
sidering that this network was significantly older than the others, it went through the
most modifications. Basically, it was composed of the following layers: convolution, sub-
sampling, convolution, subsampling, fully connected (originally implemented as convolu-
tional), fully connected, and output. As subsampling layers had learnable parameters, we
converted them to convolutions, with filter (kernel) size and stride equal to 2×2×2, thus
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keeping the subsampling behavior. The main difference was in the connection scheme
between S2 (second layer, subsampling) and C3 (third layer, convolutional). In the orig-
inal work, these connections had a very particular arrangement, which we converted to
a dropout layer with probability of 40%. Also, similarly to the original architecture, if
we adapted the last convolutional layer (C5) to match the output size of the previous
layer, it would have 120 feature maps with a kernel size of 34 × 43 × 36, and this would
be extremely huge in number of parameters. So we adapted C5 kernels to 5 × 5 × 5,
and added a global average pooling layer right after it, similarly to GoogLeNet [74] and
Residual Net [32]. Naturally, the last layer contained three units (one for each class), with
a softmax function activation. The resulting model contained five convolutional layers,
followed by two fully-connected layers, and the output.
The Visual Geometry Group (VGG) analyzed very deep CNN architectures, achieving
second place in the classification task at ILSVRC-2014 [68]. Basically, they designed very
uniform networks, with a number of convolutional and max-pooling layers, followed by two
fully-connected layers, and the output. Architectures ranged from 11 (configuration A) to
19 (configuration E) weight layers, i.e., considering only convolutional and fully-connected
layers. Due to its uniformity, mostly with filters of size 3 × 3, the VGG architecture is
considerably large. In the first layers, all the original input dimensions are kept, making
them consume plenty of GPU memory, while in the last layers, the dense connections
generate several parameters. Since our input data were already quite large when compared
to traditional 2D images, we adapted the VGG network configuration A by halving all
numbers of filters in convolutional layers, and all numbers of units in fully-connected
layers, while keeping filters sizes of 3 × 3 × 3 and dropout rate at 50%. Even after
reducing the network size, the first fully-connected layer of our adapted VGG-A, with
2048 units, accounted for 78 643 200 (88%) parameters. Similarly to our adaptation to
LeNet-5, in later architectures, this was solved by adding a global average pooling layer
after the last convolutional layer, and before the first fully-connected layer, drastically
reducing the number of parameters, even with deeper architectures; however, we did not
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Figure 2: Inception module
ber of filters in the previous stage. The merging of output
of the pooling layer with outputs of the convolutional lay-
ers would lead to an inevitable increase in the number of
outputs from stage to stage. While this architecture might
cover the optimal sparse structure, it would do it very inef-
ficiently, leading to a computational blow up within a few
stages.
This leads to the second idea of the Inception architec-
ture: judiciously reducing dimension wherever the compu-
tational requirements would increase too much otherwise.
This is based on the success of embeddings: even low di-
mensional embeddings might contain a lot of information
about a relatively large image patch. However, embed-
dings represent information in a dense, compressed form
and compressed information is harder to process. The rep-
resentation should be kept sparse at most places (as required
by the conditions of [2]) and compress the signals only
whenever they have to be aggregated en masse. That is,
1×1 convolutions are used to compute reductions before
the expensive 3×3 and 5×5 convolutions. Besides being
used as reductions, they also include the use of rectified lin-
ear activation making them dual-purpose. The final result is
depicted in Figure 2(b).
In general, an Inception network is a network consist-
ing of modules of the above type stacked upon each other,
with occasional max-pooling layers with stride 2 to halve
the resolution of the grid. For technical reasons (memory
efficiency during training), it seemed beneficial to start us-
ing Inception modules only at higher layers while keeping
the lower layers in traditional convolutional fashion. This is
not strictly necessary, simply reflecting some infrastructural
inefficiencies in our current implementation.
A useful aspect of this architecture is that it allows for
increasing the number of units at each stage significantly
without an uncontrolled blow-up in computational com-
plexity at later stages. This is achieved by the ubiquitous
use of dimensionality reduction prior to expensive convolu-
tions with larger patch sizes. Furthermore, the design fol-
lows the practical intuition that visual information should
be processed at various scales and then aggregated so that
the next stage can abstract features from the different scales
simultaneously.
The improved use of computational resources allows for
increasing both the width of each stage as well as the num-
ber of stages without getting into computational difficulties.
One can utilize the Inception architecture to create slightly
inferior, but computationally cheaper versions of it. We
have found that all the available knobs and levers allow for
a controlled balancing of computational resources resulting
in networks that are 3− 10× faster than similarly perform-
ing networks with non-Inception architecture, however this
requires careful manual design at this point.
5. GoogLeNet
By the“GoogLeNet” name we refer to the particular in-
carnation of the Inception architecture used in our submis-
sion for the ILSVRC 2014 competition. We also used one
deeper and wider Inception network with slightly superior
quality, but adding it to the ensemble seemed to improve the
results only marginally. We omit the details of that network,
as empirical evidence suggests that the influence of the ex-
act architectural parameters is relatively minor. Table 1 il-
lustrates the most common instance of Inception used in the
competition. This network (trained with different image-
patch sampling methods) was used for 6 out of the 7 models
in our ensemble.
All the convolutions, including those inside the Incep-
tion modules, use rectified linear activation. The size of the
receptive field in our network is 224×224 in the RGB color
space with zero mean. “#3×3 reduce” and “#5×5 reduce”
stands for the number of 1×1 filters in the reduction layer
used before the 3×3 and 5×5 convolutions. One can see
the number of 1×1 filters in the projection layer after the
built-in max-pooling in the pool proj column. All these re-
duction/projection layers use rectified linear activation as
well.
The network was designed with computational efficiency
and practicality in mind, so that inference can be run on in-
dividual devices including even those with limited compu-
tational resources, especially with low-memory footprint.
Figure 2.3: Inception module from GoogLeNet CNN architecture. Image from Szegedy
et al. [74].
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apply this technique to the VGG architecture. For comparison, in Table 2.1 we also
include our VGG-A with 512 units in the fully-connected layers.
While VGG achieved second place in ILSVRC-2014, GoogLeNet secured the first place
in the classification task [74], proposing a deep convolutional neural network architecture
named Inception. The basic idea was to increase both depth and width, while keeping
computational requirements constrained, which led to a deeper model, with fewer param-
eters, and better performance. We adapted directly from their GoogLeNet architecture,
i.e., only discarding the local response normalization [40] layer and the auxiliary networks.
We also adjusted the last average pooling layer, following the output shape of the previous
layer, and kept dropout rate at 40%. In this architecture, the number of layers actually
came from depth, where single convolutional or fully-connected layers counted as one,
while inception modules counted as two. However, each inception module internally had
six individual convolutional layers, which is depicted in Figure 2.3.
In ILSVRC-2015, Residual Network [32] won first place for classification, localization,
and detection tasks. Continuing analyses from VGG, the authors wanted to understand
whether learning better networks meant simply to stack more layers. With this study,
they found the degradation problem, where traditional models similar to VGG stopped
improving performance after a certain number of layers, and even started getting worse
afterwards. To overcome such problem, they proposed the residual function, which is
the basic building block of a Residual Network (ResNet), presented in Figure 2.4. The
idea was to create a shortcut connection between the input of a layer and the output of
the following one, in a way that these layers could simply learn nothing, and the input
would still be preserved, thus making it feasible to train very deep layers, even with
more than a hundred layers, and diminishing the degradation problem. However, due to
hardware constraints, we considered only smaller Residual Networks. We adapted ResNet
directly from the non-bottleneck 18-layer architecture, in which shortcuts with increasing
dimensions were either (A) identity shortcuts, i.e., padding with zero, or (B) projection
shortcuts, i.e., convolutions with 1 × 1 × 1 filter (kernel) size. Similarly to VGG, the
number of layers came from convolutional and fully-connected layers, with projection
convolutions not being considered in the layer count.
In summary, we adopted four main CNN architecture designs, namely, LeNet-5, VGG,
GoogLeNet, and ResNet. LeNet-5 is considerably older and smaller, so it shall have a lower
probability of overfitting. The VGG network is known for its uniformity, which makes it
relatively simple to adapt, inspect and use for a number of different tasks; however, this
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Figure 2. Residual learning: a building block.
are comparably good or better than the constructed solution
(or unable to do so in feasible time).
In this paper, we address the degradation problem by
introducing a deep residual learning framework. In-
stead of hoping each few stacked layers directly fit a
desired underlying mapping, we explicitly let these lay-
ers fit a residual mapping. Formally, denoting the desired
underlying mapping as H(x), we let the stacked nonlinear
layers fit another mapping of F(x) := H(x)−x. The orig-
inal mapping is recast intoF(x)+x. We hypothesize that it
is easier to optimize the residual mapping than to optimize
the original, unreferenced mapping. To the extreme, if an
identity mapping were optimal, it would be easier to push
the residual to zero than to fit an identity mapping by a stack
of nonlinear layers.
The formulation of F(x)+x can be realized by feedfor-
ward neural networks with “shortcut connections” (Fig. 2).
Shortcut connections [2, 33, 48] are those skipping one or
more layers. In our case, the shortcut connections simply
perform identity mapping, and their outputs are added to
the outputs of the stacked layers (Fig. 2). Identity short-
cut connections add neither extra parameter nor computa-
tional complexity. The entire network can still be trained
end-to-end by SGD with backpropagation, and can be eas-
ily implemented using common libraries (e.g., Caffe [19])
without modifying the solvers.
We present comprehensive experiments on ImageNet
[35] to show the degradation problem and evaluate our
method. We show that: 1) Our extremely deep residual nets
are easy to optimize, but the counterpart “plain” nets (that
simply stack layers) exhibit higher training error when the
depth increases; 2) Our deep residual nets can easily enjoy
accuracy gains from greatly increased depth, producing re-
sults substantially better than previous networks.
Similar phenomena are also shown on the CIFAR-10 set
[20], suggesting that the optimization difficulties and the
effects of our method are not just akin to a particular dataset.
We present successfully trained models on this dataset with
over 100 layers, and explore models with over 1000 layers.
On the ImageNet classification dataset [35], we obtain
excellent results by extremely deep residual nets. Our 152-
layer residual net is the deepest network ever presented on
ImageNet, while still having lower complexity than VGG
nets [40]. Our ensemble has 3.57% top-5 error on the
ImageNet test set, and won the 1st place in the ILSVRC
2015 classification competition. The extremely deep rep-
resentations also have excellent generalization performance
on other recognition tasks, and lead us to further win the
1st places on: ImageNet detection, ImageNet localization,
COCO detection, and COCO segmentation in ILSVRC &
COCO 2015 competitions. This strong evidence shows that
the residual learning principle is generic, and we expect that
it is applicable in other vision and non-vision problems.
2. Related Work
Residual Representations. In image recognition, VLAD
[18] is a representation that encodes by the residual vectors
with respect to a dictionary, and Fisher Vector [30] can be
formulated as a probabilistic version [18] of VLAD. Both
of them are powerful shallow representations for image re-
trieval and classification [4, 47]. For vector quantization,
encoding residual vectors [17] is shown to be more effec-
tive than encoding original vectors.
In low-level vision and computer graphics, for solv-
ing Partial Differential Equations (PDEs), the widely used
Multigrid method [3] reformulates the system as subprob-
lems at multiple scales, where each subproblem is respon-
sible for the residual solution between a coarser and a finer
scale. An alternative to Multigrid is hierarchical basis pre-
conditioning [44, 45], which relies on variables that repre-
sent residual vectors between two scales. It has been shown
[3, 44, 45] that these solvers converge much faster than stan-
dard solvers that are unaware of the residual nature of the
solutions. These methods suggest that a good reformulation
or preconditioning can simplify the optimization.
Shortcut Connections. Practices and theories that lead to
shortcut connections [2, 33, 48] have been studied for a long
time. An early practice of training multi-layer perceptrons
(MLPs) is to add a linear layer connected from the network
input to the output [33, 48]. In [43, 24], a few interme-
diate layers are directly connected to auxiliary classifiers
for addressing vanishing/exploding gradients. The papers
of [38, 37, 31, 46] propose methods for centering layer re-
sponses, gradients, and propagated errors, implemented by
shortcut connections. In [43], an “inception” layer is com-
posed of a shortcut branch and a few deeper branches.
Concurrent with our work, “highway networks” [41, 42]
present shortcut connections with gating functions [15].
These gates are data-dependent and have parameters, in
contrast to our identity shortcuts that are parameter-free.
When a gated shortcut is “closed” (approaching zero), the
layers in highway networks represent non-residual func-
tions. On the contrary, our formulation always learns
residual functions; our identity shortcuts are never closed,
and all information is always passed through, with addi-
tional residual functions to be learned. In addition, high-
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Figure 2.4: Building block of Residual Network (ResNet) CNN architecture. Image
from He et al. [32].
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characteristic also makes it large in number of parameters and in hardware requirements.
These drawbacks were overcome in both GoogLeNet and ResNet architectures, which
also adopted very specific building blocks, making it possible to extract more complex
patterns from data, while also increasing the number of layers and reducing the number
of parameters. The idea was to explore different architectures and understand how they
would behave in the AD task.
To avoid overfitting, we adopted regularization with L1 and L2 norms. In L1, this
effect is achieved by minimizing the absolute values of the weights, while in L2, this is
done with their squared values. In principle, L2 norm tends to produce diffuse and small
numbers, while L1 tends to produce sparse numbers. This property makes L1 particularly
interesting to handle noisy data, acting as a feature selection algorithm, which could help
us better visualize and explain what the CNN has actually learned. However, in general,
L2 can be expected to provide superior results over L1.
All network architectures, and their optimization were implemented using upstream
(i.e., latest version from the code repository) Lasagne [15], which is a deep learning
framework based on Theano [1]. At the time this research was performed, we used a
development version of Lasagne 0.2, and a development version of Theano 0.9.0, with
Python 2.7.6, CUDA 7.5, and CuDNN 5. We additionally used scikit-learn 0.18.1 [57]
and numpy 1.11.3 [81].
2.3 Domain Adaptation
In addition to the brain processing and CNN pipelines, we also considered a domain adap-
tation approach. In our method, we trained a system using one dataset, and evaluated
it on a different dataset (i.e., CADDementia). Even though they are related, such dif-
ference means that the source data distribution could be different from the target data
distribution. Thus, it should be possible to improve results further by adapting the pre-
viously trained system to the new dataset, even if using a small number of samples from
this target domain. It comes as no surprise that the best methods in the CADDementia
challenge, at some point, did use available data from both its training and test sets in
their optimization pipeline.
In our domain adaptation approach, we started with our previously optimized CNN.
Then, we used this CNN to extract features from the complete target dataset (i.e., CAD-
Dementia), using one of the last layers in the network as output. After, we normalized
these features to zero mean and unit variance, using only the target training set to compute
the parameters, which more closely relates to a real-world scenario. With the normalized
data, we optimized a one-versus-rest logistic regression [52] on the complete target train-
ing set. In order to find the best parameters for this classifier, we used grid search with
leave-one-out cross-validation. Then, we finally had a system that was enhanced for the
target domain, making it possible to output improved classification probabilities for each
sample in the target domain. This pipeline is similar to a transfer-learning approach [66].
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Chapter 3
Experimental Setup
Given that training a CNN from scratch usually requires massive amounts of data, we
gathered as many different imaging sources as possible. To the best of our knowledge,
we collected the largest AD sMRI dataset ever, comprising 23 165 images, which is orders
of magnitude larger than commonly analyzed sets, as we discuss next. We additionally
describe our optimization approach, including associated parameters.
3.1 Data
In our data collection process, we considered the following datasets:
• ADNI [54], including ADNI1, ADNIGO, ADNI2, and ADNIDOD [8] studies
• AIBL [19]
• CADDementia [9]
• MIRIAD [48]
• OASIS, including cross-sectional [49], and longitudinal [50] studies
• AddNeuroMed [46]
ADNI1 originally included three participant groups: CN, MCI and AD. Starting in
ADNIGO, the MCI stage was split into two: early MCI (eMCI) and late MCI (lMCI).
Later, in ADNI2, a significant memory concern (SMC) group was added. We refer the
reader to Beckett et al. [8] for more details.
Similarly to ADNI1, both AIBL and CADDementia sets were composed of CN, MCI,
and AD stages, whereas both MIRIAD and OASIS sets contained only CN and AD.
Unfortunately, ADNIDOD did not have Alzheimer’s diagnoses information, thus we did
not include the corresponding images in our analyses. We also did not use AddNeuroMed
due to agreement restrictions.
Since one of our main goals was achieving a good result in the CADDementia challenge,
we adopted only equivalent diagnoses. As such, eMCI and lMCI stages were grouped along
with MCI, and SMC was not considered. From these datasets, we downloaded all available
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Dataset Subjs. Group Images
Age (years) Female
(%)
1.5 T
(%)Med Avg ± Std Min Max
Dset.
1 845
All 9 149 76.6 76.3± 6.9 54.6 93.0 42.2 82.2
CN 2 701 76.7 77.2± 5.1 60.0 92.8 50.2 80.5
MCI 4 845 76.5 76.0± 7.4 54.6 90.9 35.3 83.0
AD 1 603 76.5 76.1± 7.9 55.2 93.0 49.5 82.5
Dset.
1
Train.
591
All 6 314 76.5 76.2± 6.9 54.6 93.0 43.4 82.6
CN 1 809 77.2 77.3± 4.9 60.0 90.8 49.5 81.3
MCI 3 399 76.1 75.7± 7.3 54.6 90.9 36.3 83.0
AD 1 106 75.9 76.1± 7.9 55.2 93.0 55.3 83.5
Dset.
1
Val.
84
All 951 76.4 75.8± 6.8 56.2 89.2 40.5 82.8
CN 301 75.7 76.5± 4.8 65.2 88.6 58.5 79.7
MCI 501 78.2 76.7± 6.7 56.2 89.2 28.5 83.8
AD 149 72.0 71.2± 8.6 56.5 85.0 44.3 85.2
Dset.
1
Test
170
All 1 884 77.2 77.0± 6.9 56.7 92.8 38.7 80.4
CN 591 76.2 77.2± 5.6 63.3 92.8 47.9 78.5
MCI 945 77.7 76.5± 7.8 56.7 90.9 35.1 82.4
AD 348 79.7 78.0± 6.3 63.1 87.7 33.0 78.2
Dset.
2 1 503
All 15 885 75.8 75.4± 7.3 54.6 95.8 44.0 53.3
CN 4 646 76.8 76.9± 5.8 56.3 95.8 50.0 56.5
MCI 8 940 75.0 74.6± 7.7 54.6 93.5 40.0 50.5
AD 2 299 76.4 75.8± 7.8 55.2 93.0 47.5 57.5
Dset.
3 1 715
All 18 303 75.8 75.5± 7.4 54.6 95.8 43.5 48.2
CN 5 361 76.7 76.9± 6.0 56.3 95.8 50.0 52.5
MCI 10 306 75.0 74.6± 7.7 54.6 93.6 39.5 45.5
AD 2 636 76.2 75.8± 7.9 55.2 93.0 45.9 50.2
Dset.
4 2 984
All 23 165 75.0 73.5± 11.7 18.0 98.0 46.5 55.5
CN 8 462 75.0 71.3± 16.1 18.0 97.0 53.9 62.8
MCI 10 460 75.0 74.7± 7.7 54.6 96.0 39.6 45.1
AD 4 243 75.4 75.3± 7.9 55.0 98.0 48.4 66.3
CADD.
Train. 30
All 30 65.0 65.2± 6.9 54.0 80.0 43.3 0.0
CN 12 62.0 62.3± 6.1 55.0 79.0 25.0 0.0
MCI 9 68.0 68.0± 8.2 54.0 80.0 44.4 0.0
AD 9 67.0 66.1± 5.0 57.0 75.0 66.7 0.0
CADD.
Test 354 All 354 65.0 65.1± 7.8 46.0 88.0 39.8 0.0
Table 3.1: Datasets summaries: number of subjects, number of images, descriptive age
statistics, image-wise percentage of females (vs. males), and image-wise percentage of 1.5
T field strength (vs. 3.0 T).
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raw T1-weighted sMRI scans associated with Alzheimer’s, i.e., we did not download any
pre- or post-processed image.
To isolate possible confounding factors, we made a distinction between MP-RAGE
and IR-SPGR/IR-FSPGR sequences, and aggregated different data sources and sequence
techniques in steps. While all ADNI sets had both MP-RAGE and IR-SPGR/IR-FSPGR,
AIBL and OASIS had only MP-RAGE, and MIRIAD had only IR-FSPGR. For more
details on MP-RAGE and IR-SPGR/IR-FSPGR, we refer the reader to Jack et al. [36], Lin
et al. [45]. The resulting datasets, summarized in Table 3.1, are:
• Dataset 1: ADNI1 (MP-RAGE only)
• Dataset 2: ADNI1, ADNIGO, and ADNI2 (MP-RAGE only)
• Dataset 3: ADNI1, ADNIGO, and ADNI2 (all)
• Dataset 4: ADNI1, ADNIGO, ADNI2, AIBL, MIRIAD, and OASIS (all)
For each dataset, we created training, validation, and test splits, which was done as
follows. In Dataset 1, we randomly split the corresponding subjects, trying to keep the
original age, sex, and diagnostic stratification across each set, with 70% of subjects for
training, 10% for validation, and 20% for testing. In each subsequent dataset, we first
assigned images from previous subjects to the respective set, then we proceeded with the
stratified random split considering only new subjects. We also present split summaries
for Dataset 1 in Table 3.1. It is important to note that we removed a few questionable
images, for instance, with more than one image for the same identifier, mismatch between
identifier and folder name, as well as corrupted images or without diagnosis information.
3.1.1 ADNI
Data used in the preparation of this article were obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database (https://adni.loni.usc.edu). The ADNI
was launched in 2003 by the National Institute on Aging (NIA), the National Institute
of Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug Administration
(FDA), private pharmaceutical companies and non-profit organizations, as a $60 million,
5-year public-private partnership. The primary goal of ADNI has been to test whether
serial MRI, PET, other biological markers, and clinical and neuropsychological assessment
can be combined to measure the progression of MCI and early AD. Determination of
sensitive and specific markers of very early AD progression is intended to aid researchers
and clinicians to develop new treatments and monitor their effectiveness, as well as lessen
the time and cost of clinical trials.
The Principal Investigator of this initiative is Michael W. Weiner, MD, VA Medical
Center and University of California - San Francisco. ADNI is the result of efforts of many
co-investigators from a broad range of academic institutions and private corporations,
and subjects have been recruited from over 50 sites across the U.S. and Canada. The
initial goal of ADNI was to recruit 800 subjects but ADNI has been followed by ADNI-
GO and ADNI-2. To date these three protocols have recruited over 1500 adults, ages 55
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to 90, to participate in the research, consisting of cognitively normal older individuals,
people with early or late MCI, and people with early AD. The follow up duration of
each group is specified in the protocols for ADNI-1, ADNI-2 and ADNI-GO. Subjects
originally recruited for ADNI-1 and ADNI-GO had the option to be followed in ADNI-2.
For up-to-date information, see http://www.adni-info.org.
3.1.2 AIBL
Data was collected by the AIBL study group. AIBL study methodology has been reported
previously [19].
3.2 Metrics and Optimization
To compare different methods, the CADDementia challenge adopted a number of metrics.
The main evaluation measure was the traditional classification accuracy, which is basically
the number of correctly classified samples divided by the number of all samples. Even
though this performance value does not take into account class priors, the challenge
organization considered that class sizes were not very different, regarding this metric
as a better approach for the overall classification accuracy. Additionally, the receiver
operating characteristic (ROC) curve and the respective area under the curve (AUC)
were considered, as they provide metrics that are independent of the threshold chosen for
classification. Also, since AUC does not traditionally depend on class sizes, the challenge
adopted an AUC measure that does not rely on class priors. Finally, the true positive
fraction (TPF) for each class was calculated, which is the number of correctly classified
samples of a given class divided by the number of all samples from that class. According
to the authors, TPFs for diseases (AD and MCI) can be interpreted as the two-class
sensitivity, while TPF for CN corresponds to the two-class specificity. For more details
on the challenge’s metrics, we refer the reader to Bron et al. [9].
As we optimized and trained our networks, we compared them and selected the best
ones using the average of TPFs, since it more closely relates to the accuracy, which was
the main metric, and it does not depend on class priors. To perform the training process,
we used Adam optimizer [38], with default parameters, i.e., β1 = 0.9, β2 = 0.999, and
 = 10−8. With a small sample of images, we empirically decided to begin with a learning
rate of α = 10−4, and settled to a batch size of three (for VGG architectures) or nine (for
all the others), mainly due to GPU memory limitations, even though we only used GPUs
with 12 GB of dedicated memory. Finally, we adopted Glorot uniform initialization [28]
with scaling factor of
√
2, i.e.,
a =
√
2 ·
√
6
fanin + fanout
(3.1)
W ∼ U [−a, a] (3.2)
where fanin is the number of input units of the weight tensor and fanout is the number
of output units of the weight tensor.
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Chapter 4
Results and Discussions
Accountability has become an important aspect in machine learning lately [30], and it
is even more critical in the medicine area. Automatic systems that present impressive
results no longer suffice, being necessary to also explain how and why they achieved such
performances, and determine when they are applicable, thus actually helping specialists
in their tasks.
Given that, we now dive into more details of our study. We better describe our
optimization process, specifying steps taken to handle overfitting problems. Then, we
report performance results, including previously described metrics, along with efficiency
measurements. Finally, we discuss our best CNN model, providing further insights into
its functionality, and how it processes data to make predictions.
4.1 Optimization
As stated earlier, we determined the initial learning rate of α = 10−4, and varied a
number of configurations in each architecture, trying to achieve the best accuracy in the
CADDementia training set. These options included regularization with L1 and L2 norms,
regularization strength λ, number of units in fully-connected layers, dropout rates, and
eventually the batch size, or multi-class hinge loss, instead of the traditional categorical
cross-entropy loss.
The parameters for regularization strength, number of units, and dropout rates were
also used for regularization, acting as trade-offs between model complexity and bias, thus
managing the probability to overfit. This was a major concern for us due to the large
size of our networks, and relatively small amount of data. The different batch size was
an experiment to compare the behavior of all networks with the same batch size of three.
Given that support vector machine (SVM) [13] classifiers usually present interesting re-
sults, and had also been successfully used for Alzheimer’s biomarker identification before,
we also experimented with the multi-class hinge loss.
In general, we varied regularization strength λ in powers of 10, between 10−5 and 102,
number of units in fully-connected layers in powers of 2, between 32 and 2048, and dropout
rate with steps of 10 percentage points, between 40% and 90%, including 95%, 99%, and
99.9%. Note that some networks had specific parameters, i.e., these variations did not
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(a) Overfitting with λ = 10−2.
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(b) Underfitting with λ = 10−1.
Figure 4.1: Visualization of categorical cross-entropy loss and average TPF during opti-
mization: overfitting vs. underfitting.
apply to all evaluated architectures. We followed a greedy approach, by first tuning
regularization strength with L2 norm, followed by number of units, and then dropout
rates. Next, we evaluated batches of size three for all networks, L1 norm, multi-class
hinge loss, and, finally, larger datasets.
Regarding the batch size, we always selected the same number of samples from each
class to form a batch, and we worked with a total batch size of either three or nine samples,
depending on the network architecture. An epoch consisted of randomly sampling each
class, limited by the class with fewer images, then the epoch was finished, and the next
one started with a new random sampling.
We observed that, at some point, most networks would either underfit or overfit,
presenting erratic metrics, with high variations between epochs. This is illustrated in
Figure 4.1, where we plot our first VGG architecture, with 2048 units in fully-connected
layers, and regularization strengths λ of 10−2 and 10−1 for L2 norm. To overcome this
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Dataset Median Avg ± Std Min Max
1 11.6 11.6± 2.7 7.7 25.3
2 11.8 12.2± 3.6 4.3 122.5
3 11.9 12.2± 3.5 4.3 122.5
4 11.6 11.8± 3.3 4.3 122.5
CADD 11.9 13.4± 5.6 7.5 41.2
Table 4.1: Efficiency break down for brain extraction and normalization time, in minutes.
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Figure 4.2: Histogram and kernel density estimation plots of brain extraction and nor-
malization times for Dataset 4, in minutes.
situation, we saved only the model that presented the best average TPF in the respective
validation set, making sure it would optimize for at least another 50 epochs without
further improvement, with a hard limit of 200 epochs.
4.2 Performance
We first analyze the efficiency of our processing pipeline, divided in brain image, CNN,
and domain adaptation stages. In Table 4.1, we present some statistics for the execution
time of brain extraction and normalization steps. Each row represents a complete dataset,
e.g., Dataset 4 includes all previews computations, plus its own. CADD comprises both
CADDementia training and test sets. In Figure 4.2, we plot a histogram and a kernel
density estimation of this execution time for Dataset 4, which is our largest, and contains
23 165 volumes. It is interesting to note that only 151 (0.7%) images took longer than
25 minutes to process. Each process used two cores in a shared cluster of commodity
hardware, such as Intel R© Xeon R© CPU E5645 at 2.40 GHz, and around 2 GB of RAM.
To train our CNNs, we used three different models of NVIDIA GPUs: GeForce GTX
TITAN X (Maxwell microarchitecture), Tesla K40c, and Tesla K80. Training usually
lasted for about 100 epochs, taking around 4 days to complete. We performed a total of
121 experiments. In Table 4.2, we present the processing time of our best network (VGG
512), which includes data loading time, considering all epochs from Dataset 1 validation
set. In other words, to provide these values, we aggregated all experiments performed
with the VGG 512 architecture, so we could have a better confidence. We divided the
complete set time by the number of samples in the set, with 1 504 epochs on GeForce
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GPU Median Avg ± Std Min Max
TITAN X 0.122 0.152± 0.100 0.098 1.011
Tesla K40c 0.298 0.348± 0.101 0.295 0.855
Table 4.2: Efficiency break down for our best network (VGG 512) processing time, in
seconds.
GTX TITAN X, and 81 epochs on Tesla K40c. The grid search for domain adaptation
took less than one minute to complete, while the classification of all 354 samples from
CADDementia test set happened in about one millisecond.
In summary, our method is expected to provide an output for an input volume in less
than 15 minutes, with extreme cases taking a little longer than 2 hours. To put it into
perspective, this processing time contrasts with the current best method in CADDementia
challenge, which needs 19 hours of computation [69]. In other words, our method is nearly
10× faster, considering the worst case scenario, or almost 80× faster, on average. We
understand that, given the challenge date, such execution time comparison is not always
fair, considering most methods of that time did not employ deep learning approaches.
However, we also understand that all these techniques are solving essentially the same
problem, i.e., AD diagnosis, and, in this sense, such comparison remains valid, and it is
part of method evolution.
Regarding performance metrics in terms of results, we present our best configuration
for each network architecture in Table 4.3. The best VGG had 512 units in each fully-
connected layer, and the best ResNet used the projection shortcut (B). We also include our
main optimization metric, average TPF (avgTPF), for the training set of CADDementia,
with our top value being 75.9%, which translated to 76.7% in accuracy. All these results
were found while optimizing the networks with Dataset 1.
Architecture avgTPF Norm λ Dropout
LeNet-5 56.5% L2 10−2 40%
VGG 512 75.9% L2 10−4 50%
GoogLeNet 58.3% L1 10−3 80%
ResNet B 60.2% L2 10−2 −
Table 4.3: Performance results (average TPF) of our best CNN architectures, and respec-
tive configurations.
As initially expected, L2 norm performed better for almost all architectures. The best
GoogLeNet using L2 achieved 57.4%, which is pretty close to the one using L1 (58.3%),
while the L1 norm performed considerably worse for the other networks. ResNet with
identity shortcuts (A) achieved 57.4%, which is slightly inferior to the projection shortcut
(B), with 60.2%, being a similar difference found in the original work [32]. we hypothesize
that deeper architectures did not achieve the highest scores because they tend to take
advantage of larger datasets, which is not exactly our scenario.
A batch size of three, instead of nine, only produced significantly worse results, in-
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Model Dataset Split Accuracy
TPF AUC
CN MCI AD All CN MCI AD
ADNet Dset.1
Train. 60.6 89.6 36.7 86.8 87.9 90.3 80.6 88.8
Val. 44.1 71.1 22.4 62.4 68.9 72.2 56.9 72.5
Test 43.6 67.3 21.1 64.7 68.0 73.9 57.0 68.9
ADNet CADD Train. 76.7 83.3 55.6 88.9 90.3 92.1 83.1 96.3Test 51.4 77.5 27.9 46.6 68.5 70.5 61.2 73.6
ADNet
-DA CADD
Train.* 76.7 75.0 55.6 100.0 88.5 90.7 79.4 95.8
Train. 90.0 83.3 88.9 100.0 98.0 95.8 97.9 100.0
Test 52.3 68.2 37.7 49.5 70.9 72.8 60.5 79.0
Table 4.4: Multiple performance results of our best CNN, in percentage. Train.* refers
to leave-one-out cross-validation results.
dicating that our best VGG model could potentially achieve even better results, using
GPUs with larger memory or a multi-GPU framework implementation. Similarly, multi-
class hinge loss did not improve our results. Most surprisingly, Dataset 1, our smaller,
presented the best performances, with Dataset 2 achieving as high as 72.2% on average
TPF. We hypothesize that this happened due to the higher diversity of data sources and
conditions in larger sets, indicating that a smaller but more cohesive dataset should be
sufficient for optimization.
Considering our best network model (VGG 512), we present all performance metrics in
Table 4.4. We named our CNN approach ADNet (Alzheimer’s Disease Network), with the
domain adaptation method being ADNet-DA, and submitted our prediction scores to the
CADDementia challenge. As of this writing, there were 48 different submissions, including
ours1. Similarly to reported results [9], we did expect a drop in results for the test set,
when comparing to the training set. However, with so few samples to estimate accuracy,
our evaluation was overly optimistic, even if optimizing our method on a completely
different dataset.
In general, ADNet presented promising results in the CADDementia training set, with
the exception of MCI TPF. However, the decrease in MCI and AD TPFs between training
and test sets were higher than expected. As such, this method achieved an interesting
two-class specificity, with a modest two-class sensitivity, meaning it performs better at
determining healthy patients. Regarding accuracy in the test set, ADNet ranked in 25th,
tied with two other systems, meaning it outperformed 22 submissions. Also, this result is
only statistically different, with a 95% confidence interval, from the first one, and the last
three systems. Considering the fact that, to the best of our knowledge, we were the first
group that did not use any domain specific information for this task, we can affirm that our
CNN method did learn meaningful patterns automatically. The corresponding receiver
operating characteristic (ROC) for CADDementia test set is displayed in Figure 4.3, and
the respective confusion matrix is in Table 4.5.
As for the domain adaptation approach, we extracted 512 features from the second-
1https://caddementia.grand-challenge.org/results_all/ [Online; accessed 2019-01-27]
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Figure 4.3: Receiver operating characteristic (ROC) curve for ADNet, provided by CAD-
Dementia.
True
CN MCI AD
CN 28.2 21.2 11.3
Pred. MCI 5.6 9.6 4.2
AD 2.5 3.7 13.6
Table 4.5: Confusion matrix (in percentage) for ADNet, provided by CADDementia.
to-last layer of ADNet, then we performed a grid search on the parameters of a logistic
regression classifier. Using the best parameters found, most importantly, C = 0.001, we
optimized this classifier on the complete training set, and applied it to output classifi-
cation probabilities for each sample from the challenge. We also submitted these pre-
dictions to CADDementia, naming it ADNet-DA (ADNet with domain adaption), and
the corresponding results are also indicated in Table 4.4. This method ranked in 21st,
outperforming 27 submissions, with statistical difference from the first one, and the last
four systems.
Considering this approach, we reported the leave-one-out cross-validation results in
the training set while performing a grid search, and also the results in this same set after
the last optimization with all training samples. As expected, developing and evaluating a
system on the same data overestimates its generalization performance; however, even our
cross-validation attempt did not significantly improved our estimations for the test set. In
comparison with ADNet, ADNet-DA improves both MCI and AD TPFs, while decreasing
CN TPF, with an overall improvement of almost one percentage point in accuracy, which
shows that domain adaptation is indeed an important technique. The corresponding re-
ceiver operating characteristic (ROC) for CADDementia test set is displayed in Figure 4.4,
and the respective confusion matrix is in Table 4.6.
In closing, to the best of our knowledge, we are the first group to propose end-to-end
training a very deep 3D CNN for the multiclass AD biomarker identification task, and the
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Figure 4.4: Receiver operating characteristic (ROC) curve for ADNet-DA, provided by
CADDementia.
True
CN MCI AD
CN 24.9 17.8 8.5
Pred. MCI 9.3 13.0 6.2
AD 2.3 3.7 14.4
Table 4.6: Confusion matrix (in percentage) for ADNet-DA, provided by CADDementia.
first one to submit such an approach to CADDementia. However, we are the second to
use deep learning on this challenge, with Dolph et al. [18] being the pioneers. One of their
systems ranked 7th, with 56.8% accuracy, while the other ranked 25th, tied with ADNet on
51.4%. This shows that our ADNet-DA method was able to outperform a deep-learning
system that uses domain-specific information, which demonstrates the effectiveness of the
approach proposed in this work.
4.3 Accountability
Understanding the decision-making process of a machine-learning algorithm has become
crucial lately, and even more so in medicine. To work in the real world, an algorithm must
not only present impressive performance results, but it also needs to demonstrate how
predictions are generated. This has become even more critical in recent years with rules
such as the General Data Protection Regulation (GDPR), which also brought explainable
artificial intelligence (XAI) to the spotlight.
Explaining what and how a neural network has learned is an open problem, with a
rapidly evolving research field. In order to better understand what our model is analyzing
in brain images and how it is done, we present here a number of visualization approaches,
considering the most used techniques in accountable machine learning for neural networks.
Some of these approaches were also recently explored by Rieke et al. [59].
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Figure 4.5: Weights visualization, with each row representing a complete filter of size
3× 3× 3 from the first convolutional layer.
4.3.1 Weights
Similarly to Krizhevsky et al. [40], we plot 3 out of 32 filters from our first convolutional
layer in Figure 4.5. While their kernels were of size 11×11×3, presenting some interesting
smooth and colorful patterns, our kernels are 3× 3× 3 in grayscale, producing less than
ideal images for visualization. Nonetheless, there are some three dimensional patterns
in our filters, as can be observed in contrasting brighter and darker weights within and
across planes. The spatial distribution of white and black voxels represent interesting 3D
border structures that are emphasized by these filters.
4.3.2 Activations
Another traditional approach for visualization is to show outputs of activation functions
from the network, after processing an input. Activation is simply the result of a mathe-
matical function. To this end, we selected one sample from each class in CADDementia
training set that maximally activated the corresponding output probability. Specifically,
they were train_vumc_007 (CN), train_emc_007 (MCI), and train_emc_009 (AD).
Considering the first convolutional layer, we had 32 outputs of dimensions 145×182×155.
For each input image, we selected the output with maximum total activation, out of 32,
which were then zero-padded to the original atlas dimensions of 193 × 229 × 193, and
plotted in Figure 4.6. These outputs represent some of the initial patterns that the net-
work learned to be the most relevant for this task, which are then non-linearly combined
with additional and more complex patterns before the final classification. The idea is that
brighter regions are more important to the network processing pipeline.
According to these images, it is possible to see that the regions considered significant
for the CN processing pipeline seem to reveal larger clusters distributed across the gray
matter of the brain, and randomly distributed small agglomerates in the white matter.
Moreover, we can also note an edge enhancement in the interface between ventricles and
gray and white matter. This result can be interpreted in the light of findings from the
neuroimaging field: first, Alzheimer’s is a disease originally known to mainly affect gray
matter, and a widespread atrophy can be observed in AD brains; MCI subjects, in turn,
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Figure 4.6: Anatomical planes of individuals from each group, considering the output
with maximum total activation after the first convolutional layer. Coordinates are in
MNI space.
present a gray matter atrophy similarly distributed but less intense than that of AD
group [7]. One could speculate that such a pattern of activation in the first convolutional
layer for the CN processing perhaps reflects the preservation of gray matter for this group.
Interestingly, the regions with largest activation within these MCI and AD images
include gray and white matter equally. This increased importance in white matter re-
gions may indicate that abnormalities in this area may also play an important role in
the pathogenesis and diagnosis of the disease. In fact, several neuroimaging studies have
found that AD patients have extensive, more severe and widespread white matter damage
than expected [11, 85], in which axonal demyelination might occur prior to the presence of
amyloid β plaques and neurofibrillary tangles in the presymptomatic stages of AD [63]. In
addition, small-vessel cerebrovascular alterations, observed as white matter hyperintensi-
ties in MRI, independently predicted AD diagnosis as much as amyloid burden measured
by PET [58].
We also adopted this visualization approach to the last layer that still kept spatial
information. In our network, this was the fifth pooling layer, which outputs 256 images
with dimensions 5 × 6 × 5. Since each voxel in this dimension corresponds roughly to a
region of 30 × 30 × 30 voxels in the original space, we projected this layer back to the
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Figure 4.7: Anatomical planes of individuals from each group, considering the output
with maximum total activation after the last pooling layer. Coordinates are in MNI
space. Brighter regions represent areas with more activation, i.e., more important to the
network processing pipeline.
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input image, so we could have a better visualization. To this end, we first resized the
5× 6× 5 image to 145× 182× 155 with nearest neighbor interpolation, then we applied
a Gaussian filter with kernel size of 25× 25× 25 and σ = 3, in order to reduce pixelation
effects on voxel borders, thus improving visualization. Lastly, we multiplied this image
with the original input image, so we could analyze how important voxels in this pooling
layer roughly related to the brain regions, and then zero-padded to 193× 229× 193.
We generated this visualization for the same previously selected patients, considering
the output with maximum total activation, out of 256, and depicted resulting images in
Figure 4.7. These outputs represent some of the final patterns that the network learned
to be the most relevant for this task, which are still then non-linearly combined with
additional and more complex patterns before the final classification. In this visualization,
a brighter region indicate that one or more 3 × 3 × 3 patterns within this region were
considered relevant throughout the network processing pipeline.
From these images, we can observe that for the CN, there were activations in the white
and grey matter of bilateral posterior, bilateral frontal, and left temporal regions; whereas
for MCI, higher activations occurred in white and grey matter of the bilateral occipital,
temporal and frontal regions, including the transverse cistern, the medulla and the lower
pons. AD activations mainly occurred in the white and grey matter of the right frontal
and temporal regions, as well as cerebellum.
It is hard to speculate upon these findings, especially because the last convolutional
layer is at a more abstract and complex level. Moreover, the grid pattern is not anatom-
ically correlated with brain structures. Therefore, the partial volume effect definitely
impacts the observations, precluding more precise discussions.
4.3.3 Occlusions
Occlusion is a technique to visualize how and where the input image affects the output
of the network. The basic idea is to systematically hide (occlude) some regions of the
input image, making the network not activate in these specific regions, and then storing
the probabilities output. Given a class of interest, for instance AD, it is possible to
create a heatmap with the corresponding prediction for each occluded region, where most
important ones will present highest impact (with low probability), due to the occlusion.
This was originally proposed by Zeiler and Fergus [89].
There is a number of ways to hide a region of the input image and try to avoid
activations in a network. The simplest and most direct one would be to set input values
to their respective averages, which, in our case, is zero. Considering images in a range
from zero to 255, it is possible to occlude with the average value (gray), with zero (black),
with 255 (white), and even more sophisticated approaches, such as different forms of noise.
For each selected patient, we occluded (i.e., set to zero) regions of 30× 30× 30 voxels,
with a stride of 30 between regions, and created a heatmap for each corresponding diag-
nosis class. Since lower probabilities represented higher impact, we inverted these values,
and linearly normalized them between zero and one. Then, we proceeded with the same
previous steps for smoothing, padding, and multiplication by the original input image.
Resulting images are shown in Figure 4.8, where brighter regions imply higher influence,
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Figure 4.8: Anatomical planes of individuals from each group, considering the occlusion
heatmaps for the corresponding classes. Coordinates are in MNI space. Brighter regions
imply higher influence, i.e., when occluded, these regions caused more confusion to the
classifier.
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meaning that, when occluded, these regions caused more confusion to the classifier.
From the resulting images, we can see that the whole brain was equally activated
in the CN case. This happened basically because our network interprets regions with
zero as indicative of CN, thus only reassuring the previous classification, and producing
a less than ideal visualization for occlusion. For MCI, we see higher activations in the
occipital lobe, the medial superior region of the cerebellum, frontal lobe regions (e.g.,
the prefrontal cortex and a in the right hemisphere comprising the inferior, medial and
superior frontal cortex and their underlying white matter) and a posterior region of the
right parietal cortex. For AD, we see that activation patterns were more symmetrical, with
more intense activations in caudal parts of the brain such as the brainstem and ventral
areas of the temporal and frontal lobes. It is important to highlight once again that
the grid pattern has no direct correlation with anatomical structures, hindering further
speculations regarding the biological meaning of such findings.
4.3.4 Backpropagation
Finally, we investigated an approach that more closely related to the actual output deci-
sion of the network. Backpropagation [60] is a traditional technique to optimize neural
networks. In short, we calculate the gradient of the network with respect to the input,
which is used to update the network’s internal parameters. These gradients may also be
plotted, and interpreted as how much the output is affected by changes in input values;
however, this simple approach produces rather noisy visualizations. Zeiler and Fergus [89]
proposed an improvement to this technique, called deconvolution, which can be interpreted
as reversing the operations performed by the network. Even though this is an interest-
ing approach, the guided backpropagation method, originally proposed by Springenberg
et al. [71], produces even sharper visualizations. Interestingly, guided backpropagation
combines calculations from both backpropagation and deconvolution, resulting in more
detailed images. In Figure 4.9, activations are shown in hot colormap overlaid on top of
the respective registered MRI, where changes in brighter regions mean larger effect on the
prediction output.
For the CN, we can see activations distributed in a diffuse pattern, but mainly re-
stricted to cortex in the right temporal lobe (majorly in the medial temporal gyrus and
the parahippocampal gyrus), the central portion of the occipital lobe, the posterior cin-
gulum, and the posterior parietal cortex. For MCI, we can see activations in the left
posterior parietal cortex, the right anterior cingulum and the right dorsolateral prefrontal
cortex. For AD, larger activations were detected in the left posterior parietal cortex, right
temporal pole, cerebellum and more diffusively in the spherical surface of the brain.
It is interesting to note the diffuse pattern of activations in all groups, but mainly in
temporal and posterior regions of the brain. We can attempt to interpret such activations
in the context of neuroimaging findings. Although no single structure is able to differ-
entiate AD patients from CN subjects, atrophy in temporal regions is widely important
in the context of AD. The medial temporal lobe regions might be the first ones affected
in the course of the disease, presenting very early signs of neurodegeneration [37] and
correlates well with clinical symptoms even in the prodromal stage, i.e., MCI [26]. As in
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Figure 4.9: Anatomical planes of individuals from each group, considering the outputs
from guided backpropagation. Activations are displayed in hot colormap overlaid on top
of the respective registered MRI. Coordinates are in MNI space. Changes in brighter
regions, indicated in hot colormap, mean larger effect on the prediction output.
physiopathological aspects, the temporal regions mainly present intracellular aggregates of
hyperphosphorylated tau protein, which associates with reduced grey matter density [77].
The other main signature of AD, extracellular amyloid β-protein (Aβ) deposition in form
of plaques, are mainly observed in the midline regions (posterior cingulate and medial
prefrontal cortices), and parietal areas. Longitudinal studies have shown that these areas
not only are atrophic at the mild stage of AD [85], but they continue to degenerate at a
rate of about 2% to 4% per year [43, 78].
4.3.5 Embeddings
For our last visualization technique, our motivation was to understand how our data
samples were spatially distributed within internal feature representations of our network,
in order to determine whether these representations were really helpful to discriminate
between each class. To plot our data from this high-dimensional space, we first pro-
jected them into two dimensions using the t-distributed stochastic neighbor embedding
(t-SNE) [47], with principal component analysis (PCA) initialization. Considering the
outputs from a specific layer of our network, we generated an embedding with all train-
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ing and test data in CADDementia, and then colored training samples according to each
respective class. It is important to remark that this projection approach did not use label
information from training data, which was used solely to color our plots.
First, we extracted features from the second-to-last layer of our network, with 512
dimensions, which is a traditional layer used for transfer learning and domain adaptation.
Then, we considered the final layer from ADNet, which outputs classification probabil-
ities, with 3 dimensions, and also the probability outputs from ADNet-DA. Resulting
embeddings are present in Figure 4.10. Considering ADNet, even though t-SNE [47] did
not use any label information, training data points were better grouped in an internal
feature representation space, rather than in the probability output space. This indicated
that the softmax classifier used in the network did not perform as well as it could. From
these plots, we can also see that probabilities from ADNet-DA are better distributed in
comparison with ADNet, especially for AD group, while there was less confusion for MCI.
CN
MCI
AD
Unk
(a) Features from second-to-last layer.
CN
MCI
AD
Unk
(b) ADNet probabilities.
CN
MCI
AD
Unk
(c) ADNet-DA probabilities.
Figure 4.10: Features and probabilities visualizations with t-SNE projections.
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Chapter 5
Conclusions
AD is a critical disorder, to which there is still no cure, killing more people than breast
cancer and prostate cancer combined; between 2000 and 2015, deaths from AD have
increased 123% [4]. Early diagnosis is currently the most fundamental hope for patients,
benefiting their treatment and plans for the future. Magnetic resonance imaging is one
such approach that could assist specialists to diagnose this disease as soon as possible,
with the computer-aided diagnosis of dementia (CADDementia) [9] challenge launching a
standardized evaluation protocol for this difficult task.
Using data from ADNI [54], we optimized a 3D convolutional neural network with
the whole brain image as input, and the best accuracy was achieved with a network
architecture based on VGG [68]. Our method, named ADNet, achieved interesting results,
outperforming a number of other systems in prior art. Additionally, our method with
domain adaptation, called ADNet-DA, reached 52.3% in accuracy on the CADDementia
challenge test set, outperforming most submissions to this challenge, all of which using
prior information from the disease. It is important to note that these approaches are
completely automatic (i.e., there is no need for manual intervention), and, in comparison
to the state of the art, are also considerably fast.
In summary, ADNet is an adapted version of architecture VGG-A, with 11 weight
layers. The main differences, besides 3D convolutions, were halving all numbers of filters
in convolutional layers, and setting the numbers of units in fully-connected layers to
512. Considering all evaluated parameters, the best configuration used L2 norm, with
regularization strength λ equal to 10−4, and 50% of dropout rate. We hypothesize that this
particular network architecture configuration surpassed all the others in our experiments
mainly due to the fact that it tends to present strong results when evaluated alone, i.e.,
not in an ensemble. Additionally, this was a network with 11 weight layers, while the best
VGG configuration had 19 weight layers; for comparison, the best ResNet had 152 layers,
and we only considered its shorter version, with 18 layers, so the smaller difference could
also be a contributing factor. Further experiments are necessary to track down the root
cause for this finding.
Since our method did not use any domain-specific knowledge from AD, we believe
it could be directly applied to other disorders that could benefit from computer-aided
diagnosis system using sMRI as input data. In this sense, we understand our approach is
able to automatically determine meaningful patterns within data, and thus could corrob-
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orate previous findings by specialists, assist in diagnosis scenarios, and eventually help
with different or new diseases. This is supported by our explainable artificial intelligence
(XAI) techniques, including accountability visualizations.
Similarly to our ADNet-DA approach, we believe that our publicly released learned
model could be directly applied to different datasets even with very few samples. Ad-
ditionally, outputs from either an internal representation space or the final probabilities
could be used in combination with different approaches to further improve results, or
even applied to novel problems, such as The Alzheimer’s Disease Prediction Of Longitu-
dinal Evolution (TADPOLE) challenge [51], which aims at predicting future evolution of
individuals at risk.
In this research, we have learned that it is indeed possible to train a deep learning
system to help with the challenging AD biomarker identification task. Even though
we faced some difficulties with hardware, software and data limitations, our proposed
solutions proved to be satisfactory. As such, we believe that our method can be actually
employed in medical practice. While diagnosing patients, it is possible for specialists to
use ADNet network to generate a diversity of explanatory visualizations for a given image,
while ADNet-DA can assist with the diagnosis. This way, specialists can come up with a
more informed decision and in less time.
Continuing our work, there is a number of possible improvements and alternative
paths. In terms of accountability and visualization techniques, a more straightforward
next step would be to explore additional patients, which could also be achieved with group
aggregation approaches, such as calculating the mean or the median across a specific
diagnostic group. Additionally, our CNN optimization pipeline could be used with a
more recent deep learning framework, which enables multiple GPU support, for instance,
so larger batches or even larger CNN architectures are possible. Another modification
could be to use more recent network architectures, such as Inception-v4 or Inception-
ResNet-v2 [75]. Moreover, since ADNet learned an internal embedding space, it would be
possible to explicitly enforce it with a distance metric learning approach [86], for instance,
using triplet loss. It would also be interesting to explore research paths that consider the
native MRI as input, rather than going through a pre-processing pipeline that normalizes
images to a standard dimension and, as such, could potentially alter important brain
characteristics and structures.
Considering we have a relatively small dataset, when we think of data-driven meth-
ods, exploring alternatives to increase it is another promising research path. Simpler
approaches could include additional information [20], such as age, sex, mini-mental state
examination (MMSE), years of education, and genotypes. In a more complex option, it
is also possible to generate synthetic data. Given that, in principle, AD symmetrically
affects the brain [84], it is possible to simply flip input images [20]. Data augmentation
could be done at a more abstract level, by extracting MRI features similarly to ADNet-
DA, approximating these features to select distributions, and then sampling new data.
It could also be done at input image level, using techniques such as generative adver-
sarial networks (GANs) [67]. Finally, methods for learning with few samples are also
promising [27]. 
50
Acknowledgments
The authors appreciate the effort from researchers and patients in collecting and providing
all the data used in our study. We additionally thank infrastructure support for running
our experiments. Each group is explicitly acknowledged next, in alphabetical order. The
authors have no competing interests to declare.
ADNI
Data collection and sharing for this project was funded by the Alzheimer’s Disease Neu-
roimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and
DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is
funded by the National Institute on Aging, the National Institute of Biomedical Imaging
and Bioengineering, and through generous contributions from the following: Alzheimer’s
Association; Alzheimer’s Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.;
Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Com-
pany; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Health-
care; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research &
Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.;
Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; No-
vartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.;
and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is pro-
viding funds to support ADNI clinical sites in Canada. Private sector contributions are
facilitated by the Foundation for the National Institutes of Health (https://fnih.org/).
The grantee organization is the Northern California Institute for Research and Educa-
tion, and the study is coordinated by the Alzheimer’s Disease Cooperative Study at the
University of California, San Diego. ADNI data are disseminated by the Laboratory for
Neuro Imaging at the University of Southern California. This research was also supported
by NIH grants P30 AG010129 and K01 AG030514.
CADDementia
Data used in the preparation of this article were obtained from the CADDementia chal-
lenge (https://caddementia.grand-challenge.org/).
51
Microsoft Azure
Cloud computing resources were provided by a Microsoft Azure for Research award
(https://www.microsoft.com/en-us/research/academic-program/microsoft-
azure-for-research/).
MIRIAD
Data used in the preparation of this article were obtained from the MIRIAD database
(http://miriad.drc.ion.ucl.ac.uk). The MIRIAD investigators did not participate
in analysis or writing of this report. The MIRIAD dataset is made available through
the support of the UK Alzheimer’s Society (https://www.alzheimers.org.uk/) (Grant
RF116). The original data collection was funded through an unrestricted educational
grant from GlaxoSmithKline (Grant 6GKC).
NVIDIA
The Tesla K40 used for this research was donated by the NVIDIA Corporation.
OASIS
Grant numbers P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24
RR021382, R01 MH56584.
52
Bibliography
[1] R. Al-Rfou, G. Alain, A. Almahairi, et al. Theano: A Python framework for fast
computation of mathematical expressions. ArXiv e-prints, May 2016.
[2] M. S. Albert, S. T. DeKosky, D. Dickson, et al. The diagnosis of mild cognitive
impairment due to Alzheimer’s disease: Recommendations from the national institute
on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s
disease. Alzheimer’s & Dementia, 7(3):270–279, 2011.
[3] G. I. Allen, N. Amoroso, C. Anghel, et al. Crowdsourced estimation of cognitive
decline and resilience in Alzheimer’s disease. Alzheimer’s & Dementia, 12(6):645–
653, 2016.
[4] Alzheimer’s Association. 2018 Alzheimer’s disease facts and figures. Alzheimer’s &
Dementia, 14(3):367–429, 2018.
[5] B. B. Avants, N. Tustison, and G. Song. Advanced normalization tools (ants). Insight
J, 2:1–35, 2009.
[6] B. B. Avants, N. J. Tustison, G. Song, et al. A reproducible evaluation of ANTs
similarity metric performance in brain image registration. NeuroImage, 54(3):2033–
2044, 2011.
[7] M. L. F. Balthazar, C. L. Yasuda, F. R. Pereira, et al. Differences in grey and white
matter atrophy in amnestic mild cognitive impairment and mild Alzheimer’s disease.
European Journal of Neurology, 16(4):468–474, 2009.
[8] L. A. Beckett, M. C. Donohue, C. Wang, et al. The Alzheimer’s disease neuroimaging
initiative phase 2: Increasing the length, breadth, and depth of our understanding.
Alzheimer’s & Dementia, 11(7):823–831, 2015.
[9] E. E. Bron, M. Smits, W. M. van der Flier, et al. Standardized evaluation of al-
gorithms for computer-aided diagnosis of dementia based on structural mri: The
CADDementia challenge. NeuroImage, 111:562–579, 2015.
[10] T. Brosch and R. Tam. Efficient training of convolutional deep belief networks in
the frequency domain for application to high-resolution 2d and 3d images. Neural
Computation, 27(1):211–227, 2015. PMID: 25380341.
[11] F. Caso, F. Agosta, D. Mattavelli, et al. White matter degeneration in atypical
Alzheimer disease. Radiology, 277(1):162–172, 2015. PMID: 26018810.
53
[12] D. L. Collins, A. P. Zijdenbos, W. F. C. Baaré, et al. Animal+insect: Improved
cortical structure segmentation. In A. Kuba, M. Šáamal, and A. Todd-Pokropek, ed-
itors, International Conference on Information Processing in Medical Imaging, pages
210–223. Springer, 1999.
[13] C. Cortes and V. Vapnik. Support-vector networks. Machine Learning, 20(3):273–
297, Sep 1995.
[14] R. Cuingnet, E. Gerardin, J. Tessieras, et al. Automatic classification of patients
with Alzheimer’s disease from structural MRI: A comparison of ten methods using
the ADNI database. NeuroImage, 56(2):766–781, 2011. Multivariate Decoding and
Brain Reading.
[15] S. Dieleman, J. Schlüter, C. Raffel, et al. Lasagne: First release., August 2015.
[16] W. J. Dixon. Simplified estimation from censored normal samples. The Annals of
Mathematical Statistics, 31(2):385–391, 1960.
[17] K. Doi. Computer-aided diagnosis in medical imaging: Historical review, current
status and future potential. Computerized Medical Imaging and Graphics, 31(4):198–
211, 2007. Computer-aided Diagnosis (CAD) and Image-guided Decision Support.
[18] C. V. Dolph, M. Alam, Z. Shboul, et al. Deep learning of texture and structural
features for multiclass Alzheimer’s disease classification. In International Joint Con-
ference on Neural Networks (IJCNN), pages 2259–2266, May 2017.
[19] K. A. Ellis, A. I. Bush, D. Darby, et al. The australian imaging, biomarkers and
lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112
individuals recruited for a longitudinal study of Alzheimer’s disease. International
Psychogeriatrics, 21(4):672–687, August 2009.
[20] S. Esmaeilzadeh, D. I. Belivanis, K. M. Pohl, et al. End-to-end Alzheimer’s disease
diagnosis and biomarker identification. In Y. Shi, H.-I. Suk, and M. Liu, editors,
Machine Learning in Medical Imaging, pages 337–345, Cham, 2018. Springer Inter-
national Publishing.
[21] D. A. Evans, H. Funkenstein, M. S. Albert, et al. Prevalence of Alzheimer’s disease in
a community population of older persons: Higher than previously reported. JAMA,
262(18):2551–2556, 1989.
[22] F. Falahati, E. Westman, and A. Simmons. Multivariate data analysis and machine
learning in Alzheimer’s disease with a focus on structural magnetic resonance imag-
ing. Journal of Alzheimer’s Disease, 41(3):685–708, 2014.
[23] C. P. Ferri, M. Prince, C. Brayne, et al. Global prevalence of dementia: a delphi
consensus study. The Lancet, 366(9503):2112–2117, Dec 2005.
[24] V. Fonov, A. C. Evans, K. Botteron, et al. Unbiased average age-appropriate atlases
for pediatric studies. NeuroImage, 54(1):313–327, 2011.
54
[25] V. Fonov, A. Evans, R. McKinstry, et al. Unbiased nonlinear average age-appropriate
brain templates from birth to adulthood. NeuroImage, 47, Supplement 1:S102, 2009.
Organization for Human Brain Mapping 2009 Annual Meeting.
[26] G. B. Frisoni, N. C. Fox, C. R. Jack Jr, et al. The clinical use of structural MRI in
Alzheimer disease. Nature Reviews Neurology, 6:67–77, Feb 2010. Review Article.
[27] Y. Fu, T. Xiang, Y.-G. Jiang, et al. Recent advances in zero-shot recognition. ArXiv
e-prints, October 2017.
[28] X. Glorot and Y. Bengio. Understanding the difficulty of training deep feedforward
neural networks. In Y. W. Teh and M. Titterington, editors, International Conference
on Artificial Intelligence and Statistics, pages 249–256. PMLR, 13–15 May 2010.
[29] I. Goodfellow, Y. Bengio, and A. Courville. Deep Learning. MIT Press, 2016.
[30] B. Goodman and S. Flaxman. European Union regulations on algorithmic decision-
making and a “right to explanation”. ArXiv e-prints, June 2016.
[31] K. H. Gylys, J. A. Fein, F. Yang, et al. Synaptic changes in Alzheimer’s disease:
Increased amyloid-β and gliosis in surviving terminals is accompanied by decreased
psd-95 fluorescence. The American Journal of Pathology, 165(5):1809–1817, 2004.
[32] K. He, X. Zhang, S. Ren, et al. Deep residual learning for image recognition. In
The IEEE International Conference on Computer Vision and Pattern Recognition
(CVPR), pages 770–778, June 2016.
[33] E. J. Herrera, P. Caramelli, A. S. B. Silveira, et al. Epidemiologic survey of demen-
tia in a community-dwelling brazilian population. Alzheimer Disease & Associated
Disorders, 16(2):103–108, 2002.
[34] E. Hosseini-Asl, M. Ghazal, A. Mahmoud, et al. Alzheimer’s disease diagnostics
by a 3d deeply supervised adaptable convolutional network. Frontiers in bioscience
(Landmark edition), 23:584–596, January 2018.
[35] S. Ioffe and C. Szegedy. Batch normalization: Accelerating deep network training
by reducing internal covariate shift. In D. Blei and F. Bach, editors, International
Conference on Machine Learning (ICML), pages 448–456, 2015.
[36] C. R. Jack, M. A. Bernstein, N. C. Fox, et al. The Alzheimer’s disease neuroimaging
initiative (ADNI): MRI methods. Journal of Magnetic Resonance Imaging, 27(4):
685–691, 2008.
[37] G. Karas, P. Scheltens, S. Rombouts, et al. Global and local gray matter loss in mild
cognitive impairment and Alzheimer’s disease. NeuroImage, 23(2):708–716, 2004.
[38] D. P. Kingma and J. Ba. Adam: A method for stochastic optimization. ArXiv
e-prints, December 2014.
55
[39] S. Korolev, A. Safiullin, M. Belyaev, et al. Residual and plain convolutional neu-
ral networks for 3d brain mri classification. In IEEE International Symposium on
Biomedical Imaging (ISBI), pages 835–838, April 2017.
[40] A. Krizhevsky, I. Sutskever, and G. E. Hinton. Imagenet classification with deep
convolutional neural networks. In F. Pereira, C. J. C. Burges, L. Bottou, and K. Q.
Weinberger, editors, Advances in Neural Information Processing Systems 25, pages
1097–1105. Curran Associates, Inc., 2012.
[41] Y. LeCun, B. Boser, J. S. Denker, et al. Backpropagation applied to handwritten zip
code recognition. Neural Computation, 1(4):541–551, December 1989.
[42] Y. LeCun, L. Bottou, Y. Bengio, et al. Gradient-based learning applied to document
recognition. Proceedings of the IEEE, 86(11):2278–2324, November 1998.
[43] A. D. Leow, I. Yanovsky, N. Parikshak, et al. Alzheimer’s disease neuroimaging
initiative: A one-year follow up study using tensor-based morphometry correlating
degenerative rates, biomarkers and cognition. NeuroImage, 45(3):645–655, 2009.
[44] R. Li, W. Zhang, H.-I. Suk, et al. Deep learning based imaging data completion for
improved brain disease diagnosis. In P. Golland, N. Hata, C. Barillot, J. Hornegger,
and R. Howe, editors, Medical Image Computing and Computer-Assisted Intervention
(MICCAI 2014), pages 305–312. Springer, 2014.
[45] C. Lin, R. Watson, H. Ward, et al. MP-RAGE compared to 3D IR SPGR for optimal
T1 contrast and image quality in the brain at 3T. International Society for Magnetic
Resonance in Medicine (ISMRM), 14:981, 2006.
[46] S. Lovestone, P. Francis, I. Kloszewska, et al. Addneuromed–the european collabo-
ration for the discovery of novel biomarkers for Alzheimer’s disease. Annals of the
New York Academy of Sciences, 1180(1):36–46, 2009.
[47] L. v. d. Maaten and G. Hinton. Visualizing data using t-sne. Journal of Machine
Learning Research, 9(Nov):2579–2605, 2008.
[48] I. B. Malone, D. Cash, G. R. Ridgway, et al. MIRIAD–Public release of a multiple
time point Alzheimer’s MR imaging dataset. NeuroImage, 70:33–36, 2013.
[49] D. S. Marcus, T. H. Wang, J. Parker, et al. Open access series of imaging studies
(oasis): Cross-sectional mri data in young, middle aged, nondemented, and demented
older adults. Journal of Cognitive Neuroscience, 19(9):1498–1507, August 2007.
[50] D. S. Marcus, A. F. Fotenos, J. G. Csernansky, et al. Open access series of imaging
studies: Longitudinal mri data in nondemented and demented older adults. Journal
of Cognitive Neuroscience, 22(12):2677–2684, November 2009.
[51] R. V. Marinescu, N. P. Oxtoby, A. L. Young, et al. TADPOLE challenge: Prediction
of longitudinal evolution in Alzheimer’s disease. ArXiv e-prints, May 2018.
56
[52] P. McCullagh. Generalized linear models. European Journal of Operational Research,
16(3):285–292, 1984.
[53] G. M. McKhann, D. S. Knopman, H. Chertkow, et al. The diagnosis of dementia
due to Alzheimer’s disease: Recommendations from the national institute on aging-
Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease.
Alzheimer’s & Dementia, 7(3):263–269, 2011.
[54] S. G. Mueller, M. W. Weiner, L. J. Thal, et al. Ways toward an early diagnosis
in Alzheimer’s disease: The Alzheimer’s disease neuroimaging initiative (ADNI).
Alzheimer’s & Dementia, 1(1):55–66, 2005.
[55] V. Nair and G. E. Hinton. Rectified linear units improve restricted boltzmann ma-
chines. In J. Fürnkranz and T. Joachims, editors, International Conference on Ma-
chine Learning (ICML), pages 807–814. Omnipress, 2010.
[56] A. Payan and G. Montana. Predicting Alzheimer’s disease: a neuroimaging study
with 3D convolutional neural networks. ArXiv e-prints, February 2015.
[57] F. Pedregosa, G. Varoquaux, A. Gramfort, et al. Scikit-learn: Machine learning in
python. Journal of Machine Learning Research, 12(Oct):2825–2830, 2011.
[58] F. Provenzano, J. Muraskin, G. Tosto, et al. White matter hyperintensities and
cerebral amyloidosis: Necessary and sufficient for clinical expression of Alzheimer
disease? JAMA Neurology, 70(4):455–461, 2013.
[59] J. Rieke, F. Eitel, M. Weygandt, et al. Visualizing convolutional networks for mri-
based diagnosis of Alzheimer’s disease. ArXiv e-prints, August 2018.
[60] D. E. Rumelhart, G. E. Hinton, and R. J. Williams. Learning representations by
back-propagating errors. Nature, 323:533–536, Oct 1986.
[61] O. Russakovsky, J. Deng, H. Su, et al. Imagenet large scale visual recognition chal-
lenge. International Journal of Computer Vision, 115(3):211–252, 2015.
[62] M. R. Sabuncu and E. Konukoglu. Clinical prediction from structural brain mri
scans: A large-scale empirical study. Neuroinformatics, 13(1):31–46, 2015.
[63] P. S. Sachdev, L. Zhuang, N. Braidy, et al. Is Alzheimer’s a disease of the white
matter? Current Opinion in Psychiatry, 26(3):244–251, 2013.
[64] S. Sarraf, J. Anderson, and G. Tofighi. Deepad: Alzheimer’s disease classification
via deep convolutional neural networks using mri and fmri. bioRxiv, 2016.
[65] D. J. Selkoe. Alzheimer’s disease: Genes, proteins, and therapy. Physiological Re-
views, 81(2):741–766, 2001. PMID: 11274343.
[66] A. Sharif Razavian, H. Azizpour, J. Sullivan, et al. Cnn features off-the-shelf: An
astounding baseline for recognition. In The IEEE Conference on Computer Vision
and Pattern Recognition (CVPR) Workshops, pages 806–813, June 2014.
57
[67] H.-C. Shin, N. A. Tenenholtz, J. K. Rogers, et al. Medical image synthesis for data
augmentation and anonymization using generative adversarial networks. ArXiv e-
prints, July 2018.
[68] K. Simonyan and A. Zisserman. Very deep convolutional networks for large-scale
image recognition. ArXiv e-prints, September 2014.
[69] L. Sørensen, C. Igel, A. Pai, et al. Differential diagnosis of mild cognitive impairment
and Alzheimer’s disease using structural MRI cortical thickness, hippocampal shape,
hippocampal texture, and volumetry. NeuroImage: Clinical, 13:470–482, 2017.
[70] R. A. Sperling, P. S. Aisen, L. A. Beckett, et al. Toward defining the preclinical
stages of Alzheimer’s disease: Recommendations from the national institute on aging-
Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease.
Alzheimer’s & Dementia, 7(3):280–292, 2011.
[71] J. T. Springenberg, A. Dosovitskiy, T. Brox, et al. Striving for simplicity: The all
convolutional net. ArXiv e-prints, December 2014.
[72] H.-I. Suk and D. Shen. Deep learning-based feature representation for ad/mci classi-
fication. In K. Mori, I. Sakuma, Y. Sato, C. Barillot, and N. Navab, editors, Medical
Image Computing and Computer-Assisted Intervention (MICCAI), pages 583–590.
Springer, 2013.
[73] H.-I. Suk, S.-W. Lee, and D. Shen. Hierarchical feature representation and multi-
modal fusion with deep learning for AD/MCI diagnosis. NeuroImage, 101:569–582,
2014.
[74] C. Szegedy, W. Liu, Y. Jia, et al. Going deeper with convolutions. In IEEE Confer-
ence on Computer Vision and Pattern Recognition (CVPR), pages 1–9, June 2015.
[75] C. Szegedy, S. Ioffe, V. Vanhoucke, et al. Inception-v4, inception-resnet and the
impact of residual connections on learning. In AAAI Conference on Artificial Intel-
ligence, 2017.
[76] L. J. Thal, K. Kantarci, E. M. Reiman, et al. The role of biomarkers in clin-
ical trials for Alzheimer disease. Alzheimer Dis Assoc Disord, 20(1):6–15, 2006.
16493230[pmid].
[77] P. A. Thomann, E. Kaiser, P. Schönknecht, et al. Association of total tau and
phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy
in mild cognitive impairment and Alzheimer disease. J Psychiatry Neurosci, 34(2):
136–142, Mar 2009. 0001585-200903000-00007[PII].
[78] P. M. Thompson, K. M. Hayashi, G. de Zubicaray, et al. Dynamics of gray matter
loss in Alzheimer’s disease. Journal of Neuroscience, 23(3):994–1005, 2003.
[79] N. J. Tustison, B. B. Avants, P. A. Cook, et al. N4itk: Improved n3 bias correction.
IEEE Transactions on Medical Imaging, 29(6):1310–1320, June 2010.
58
[80] N. Tustison and B. Avants. Explicit b-spline regularization in diffeomorphic image
registration. Frontiers in Neuroinformatics, 7:39, 2013.
[81] S. van der Walt, S. C. Colbert, and G. Varoquaux. The numpy array: A structure
for efficient numerical computation. Computing in Science Engineering, 13(2):22–30,
March 2011.
[82] C. Wachinger and M. Reuter. Domain adaptation for Alzheimer’s disease diagnostics.
NeuroImage, 139:470–479, 2016.
[83] A. Ward, S. Tardiff, C. Dye, et al. Rate of conversion from prodromal Alzheimer’s
disease to Alzheimer’s dementia: A systematic review of the literature. Dementia
and Geriatric Cognitive Disorders Extra, 3(1):320–332, 2013.
[84] M. Weiler, F. Agosta, E. Canu, et al. Following the spreading of brain structural
changes in Alzheimer’s disease: A longitudinal, multimodal MRI study. Journal of
Alzheimer’s Disease, 47(4):995–1007, Aug 2015.
[85] M. Weiler, F. Agosta, E. Canu, et al. Following the spreading of brain structural
changes in Alzheimer’s disease: a longitudinal, multimodal mri study. Journal of
Alzheimer’s Disease, 47(4):995–1007, 2015.
[86] K. Q. Weinberger, J. Blitzer, and L. K. Saul. Distance metric learning for large
margin nearest neighbor classification. In Y. Weiss, P. B. Schölkopf, and J. C. Platt,
editors, Advances in Neural Information Processing Systems 18, pages 1473–1480.
MIT Press, 2006.
[87] B. P. Welford. Note on a method for calculating corrected sums of squares and
products. Technometrics, 4(3):419–420, 1962.
[88] B. T. Wyman, D. J. Harvey, K. Crawford, et al. Standardization of analysis sets for
reporting results from ADNI MRI data. Alzheimer’s & Dementia: The Journal of
the Alzheimer’s Association, 9(3):332–337, May 2013.
[89] M. D. Zeiler and R. Fergus. Visualizing and understanding convolutional networks. In
European Conference on Computer Vision (ECCV), pages 818–833. Springer, 2014.
